Other specified/unspecified systemic involvement of connective tissue

M13_CONNECTNAS

connective tissue disease: A disorder characterized by abnormalities in one or more of the elements of the connective tissues, typically associated with genetic defects.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M35.8, M35.9 Hospital discharge: ICD-9 — 710[8-9] Hospital discharge: ICD-8 — 7349[1-9] Cause of death: ICD-10 — M35.8, M35.9 Cause of death: ICD-9 — 710[8-9] Cause of death: ICD-8 — 7349[1-9] 2 out of 7 registries used, show all original rules.	2327
4. Check minimum number of events None	2327
5. Include endpoints None	2327
6. Filter based on genotype QC (FinnGen only)	2248

Control definitions (FinnGen only)

Control exclude: M13_SYSTCONNECT

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	M13_CONNECTNAS
CONTROL_EXCLUDE	M13_SYSTCONNECT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M35[8-9]
HD_ICD_9	710[8-9]
HD_ICD_8	7349[1-9]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M35[8-9]
COD_ICD_9	710[8-9]
COD_ICD_8	7349[1-9]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other specified/unspecified systemic involvement of connective tissue based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	14013	10660	3215
Only index persons	11603	9189	2414
Unadjusted period prevalence (%)
Whole population	0.25	0.31	0.09
Only index persons	0.29	0.34	0.09
Median age at first event (years)
Whole population	52.98	51.92	56.35
Only index persons	50.88	50.14	53.68

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2248	1783	465
Unadjusted period prevalence (%)	0.55	0.63	0.21
Median age at first event (years)	50.58	49.07	56.39

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2327: Matched controls
23269

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

XPX04

NOMESCO Finland

Angioscopy

130.3

313.4

158

L04AX01

ATC

azathioprine; systemic

15.2

307.7

450

361

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

18.7

307.7

1234

1327

I73.0

ICD-10 Finland

Raynaud syndrome

24.6

307.7

265

121

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

16384.0

307.7

1946

P01BA02

ATC

hydroxychloroquine; oral

36.3

307.7

1409

943

L04AX03

ATC

methotrexate; systemic

8.8

307.7

751

1196

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

267.1

307.7

503

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

897.9

307.7

312

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

11.9

307.7

665

756

H02AB06

ATC

prednisolone; systemic

5.4

302.8

1728

8109

XX9XE

NOMESCO Finland

Other ultrasound examination

38.9

291.6

180

M35.3

ICD-10 Finland

Polymyalgia rheumatica

18.2

276.4

228

138

L04AA06

ATC

mycophenolic acid; systemic

22.9

270.3

200

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

6.9

257.9

452

786

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

2542.3

252.6

240

C08CA05

ATC

nifedipine; systemic

7.6

251.1

393

605

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.8

219.7

1283

5687

M35.1

ICD-10 Finland

Other overlap syndromes

+∞

206.4

195

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

11.6

205.2

220

208

L88

ICPC

Rheumatoid/seropositive arthritis

8.1

201.5

290

403

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

4.9

179.3

459

1111

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

6.7

162.4

275

454

L01BA01

ATC

methotrexate; systemic

7.1

157.4

253

395

SBA10

NOMESCO Finland

Measurement of salivary flow rate

19.6

154.2

121

M05BA04

ATC

alendronic acid; oral

4.5

146.9

411

1059

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.0

144.0

1349

7346

H02AB07

ATC

prednisone; oral

3.7

143.1

572

1899

M79.0

ICD-10 Finland

Rheumatism, unspecified

6.6

134.3

229

379

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.7

131.0

337

809

M35.7

ICD-10 Finland

Hypermobility syndrome

32.7

127.0

M34.1

ICD-10 Finland

CR(E)ST syndrome

+∞

120.9

115

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

1197.0

117.8

114

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.8

107.5

375

1121

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

4.7

107.0

272

643

M13.9

ICD-10 Finland

Arthritis, unspecified

4.1

103.4

318

869

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

8.5

98.9

130

160

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

9.4

97.6

119

133

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

97.1

889

4543

73491

ICD-8 Finland

Diffuse diseases of connective tissue, Collagenosis NUD

+∞

93.4

L93.0

ICD-10 Finland

Discoid lupus erythematosus

22.6

89.9

7109X

ICD-9 Finland

Diffuse diseases of connective tissue, Unspecified diffuse connective tissue disease

+∞

89.1

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

+∞

87.0

H04.10

ICD-10 Finland

Dry eye syndrome

3.1

86.7

438

1637

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.4

84.3

344

1131

R50.9

ICD-10 Finland

Fever, unspecified

2.9

83.8

480

1921

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

5.5

82.7

167

323

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.3

80.1

1243

7818

M25.5

ICD-10 Finland

Pain in joint

2.3

79.1

971

5536

TEA00

NOMESCO Finland

Biopsy of lip

12.9

76.3

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

6.5

75.2

125

200

L04AA13

ATC

[U] leflunomide

5.8

69.9

131

236

ZX120

NOMESCO Finland

Intravenous

3.1

69.7

329

1174

M79.7

ICD-10 Finland

Fibromyalgia

4.6

69.2

174

405

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

+∞

69.1

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.9

68.4

219

610

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

7.2

67.2

102

148

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

5.6

66.5

131

247

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

7.9

65.7

119

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

10.4

64.6

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

6.5

63.5

105

167

R06.0

ICD-10 Finland

Dyspnoea

2.2

62.4

742

4093

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.0

62.1

299

1076

L04AD01

ATC

ciclosporin; systemic

7.0

61.7

143

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

61.1

394

1656

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

4.1

60.2

172

441

A02BC02

ATC

pantoprazole; systemic

2.2

59.7

1717

13066

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

59.6

651

3460

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.9

59.6

319

1216

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

592.7

59.0

R4120

NOMESCO Finland

Occupational therapy

3.3

58.9

239

776

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

58.9

623

3267

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

+∞

57.5

TGC00

NOMESCO Finland

Bronchial lavation

5.7

57.3

109

199

NH3EA

NOMESCO Finland

Feet X-ray examination with load

6.0

57.0

103

179

A07EC01

ATC

sulfasalazine; oral, rectal

3.0

56.7

281

1026

M05BA07

ATC

risedronic acid; oral

4.6

55.6

135

305

N03AX16

ATC

[U] pregabalin

2.1

54.4

651

3569

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

6.3

54.2

150

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

+∞

53.3

N02AX02

ATC

tramadol; systemic, rectal

2.0

53.0

1078

7129

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.2

52.6

581

3081

UJF32

NOMESCO Finland

Coloscopy

2.1

52.5

690

3912

GD1AD

NOMESCO Finland

Thorax CT examination

3.5

51.8

188

568

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.6

50.7

322

1336

M34.0

ICD-10 Finland

Progressive systemic sclerosis

+∞

49.1

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

6.8

48.9

116

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.8

48.8

271

1049

318

Kela drug reimbursment

Teriparatide

13.9

48.6

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.1

48.2

562

3031

L04AA01

ATC

[U] ciclosporin

7.1

48.0

106

H02AB04

ATC

methylprednisolone; systemic

2.3

47.9

429

2080

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

4.9

47.7

107

226

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

5.1

47.2

101

205

M32

ICD-10 Finland

Systemic lupus erythematosus

+∞

47.0

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.8

46.7

150

417

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

4.3

46.7

123

296

C03CA01

ATC

furosemide; systemic

2.0

46.4

685

4018

E0000UV, ,

ATC

1.9

46.3

1065

7233

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

46.0

392

1858

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.0

45.2

216

770

XG410

NOMESCO Finland

Flow-volume spirometry

3.9

45.1

138

371

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.3

44.8

178

569

NXL00

NOMESCO Finland

Biopsy of muscle

18.3

44.7

PAW37

NOMESCO Finland

Biopsy of temporal artery

65.1

44.3

M81.9

ICD-10 Finland

Osteoporosis, unspecified

3.5

44.0

162

493

A02BC03

ATC

lansoprazole; oral

1.9

43.3

753

4651

C08CA02

ATC

felodipine; oral

2.7

43.2

255

1016

L99

ICPC

Musculoskeletal disease other

5.0

43.0

198

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.2

43.0

436

2216

J01MA12

ATC

levofloxacin; systemic

2.1

42.7

473

2488

S01XA18

ATC

ciclosporin; ophthalmic

9.6

42.5

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

42.0

375

1809

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.4

41.5

157

486

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

61.2

41.3

J01FF01

ATC

clindamycin; systemic

1.9

40.5

689

4208

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

109.5

39.8

G04BE03

ATC

sildenafil; oral

8.2

39.8

M05BX04

ATC

denosumab; parenteral

2.9

39.7

197

716

D68.8

ICD-10 Finland

Other specified coagulation defects

6.8

39.6

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

393.9

39.2

M01AH01

ATC

celecoxib; oral

2.0

39.2

490

2689

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

38.6

541

3089

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

12.0

38.6

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

38.1

274

1199

H05AA02

ATC

teriparatide; parenteral

12.1

37.7

M35.5

ICD-10 Finland

Multifocal fibrosclerosis

+∞

37.6

M33.2

ICD-10 Finland

Polymyositis

193.1

36.9

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

4.3

36.8

229

M81.4

ICD-10 Finland

Drug-induced osteoporosis

13.1

36.6

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.9

36.6

112

301

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

+∞

36.5

A07AA02

ATC

nystatin; oral

2.9

36.4

181

658

ELA30

NOMESCO Finland

Biopsy of salivary gland

61.1

36.2

7108X

ICD-9 Finland

Diffuse diseases of connective tissue, Other specified diffuse diseases of connective tissue

+∞

35.5

N03AX12

ATC

[U] gabapentin; oral

2.0

35.1

438

2391

J01MA14

ATC

moxifloxacin; systemic

2.5

34.9

243

1046

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.3

34.4

290

1359

H26.3

ICD-10 Finland

Drug-induced cataract

9.7

34.2

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

342.0

34.0

WZA10

NOMESCO Finland

Extensive medical or dental certificate

6.1

33.8

A02BC01

ATC

omeprazole; systemic

1.8

33.6

674

4289

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

5.7

33.4

114

ZX140

NOMESCO Finland

Intra articular

7.1

33.1

P01BA01

ATC

chloroquine; systemic

10.1

32.7

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

32.6

986

7032

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

32.5

448

2528

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.5

32.1

210

877

R68.2

ICD-10 Finland

Dry mouth, unspecified

10.1

31.9

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

31.8

266

1241

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.0

31.1

232

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

42.8

30.9

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

3.6

30.6

101

286

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.6

30.3

179

711

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

30.1

455

2640

M05BB03

ATC

alendronic acid and colecalciferol; oral

4.1

29.9

212

J01MA02

ATC

ciprofloxacin; systemic

1.7

29.7

872

6127

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.4

29.6

208

897

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.7

29.6

264

N06AX21

ATC

duloxetine; oral

2.1

29.6

331

1730

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

29.5

727

4874

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.6

29.0

176

708

A02BC05

ATC

esomeprazole; systemic

1.6

28.9

984

7170

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

7.0

28.9

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.4

28.8

212

934

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

5.6

28.5

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

28.3

247

1170

J02AC01

ATC

fluconazole; systemic

1.6

28.2

1070

7992

M33.1

ICD-10 Finland

Other dermatomyositis

+∞

28.2

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

+∞

28.2

K74.3

ICD-10 Finland

Primary biliary cirrhosis

8.0

28.2

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.4

28.1

211

938

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

5.8

27.8

N06AA09

ATC

amitriptyline; systemic

2.2

27.7

269

1330

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

27.7

268

1324

K11.2

ICD-10 Finland

Sialoadenitis

3.3

27.5

105

327

M60.9

ICD-10 Finland

Myositis, unspecified

9.3

27.4

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.9

27.2

135

489

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

6.1

27.2

M79.1

ICD-10 Finland

Myalgia

1.9

27.1

388

2205

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

27.0

248

1199

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

26.9

887

6379

K90.0

ICD-10 Finland

Coeliac disease

3.4

26.9

100

306

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

274.1

26.8

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

26.6

926

6745

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

26.4

1034

7744

C08CA01

ATC

amlodipine; oral

1.6

26.0

822

5840

J01DB01

ATC

cefalexin; oral

1.8

25.9

1913

16719

H02AB09

ATC

hydrocortisone; systemic

3.9

25.8

199

R06AE07

ATC

cetirizine; oral

1.6

25.7

1079

8196

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.6

25.7

241

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.6

25.6

153

611

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

25.5

847

6083

R51.80

ICD-10 Finland

Headache

1.8

25.5

412

2431

EL3AE

NOMESCO Finland

Salivary gland ultrasound examination

8.0

25.2

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

4.5

25.1

138

73498

ICD-8 Finland

Diffuse diseases of connective tissue, Alii definiti

+∞

25.0

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

10.1

24.7

M35

ICD-10 Finland

Other systemic involvement of connective tissue

91.1

24.7

N35.9

ICD-10 Finland

Urethral stricture, unspecified

7.8

24.7

M01AC06

ATC

meloxicam; systemic, rectal

1.6

24.6

883

6444

M01AH02

ATC

rofecoxib; oral

2.0

24.4

313

1711

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.4

24.2

182

809

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

4.9

24.1

110

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

9.8

24.1

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

24.1

305

1660

L28

ICPC

Limited function/disability (L)

1.8

23.8

398

2369

J01FA06

ATC

roxithromycin; oral

1.6

23.7

962

7211

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

23.5

468

2930

NF1AA

NOMESCO Finland

Hip X-ray examination

2.2

23.5

210

1003

M79.6

ICD-10 Finland

Pain in limb

1.6

23.3

996

7543

XW000

NOMESCO Finland

Bone marrow biopsy

2.9

23.2

111

394

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

23.2

275

1462

C07AB07

ATC

bisoprolol; oral

1.6

23.1

1027

7841

73499

ICD-8 Finland

Diffuse diseases of connective tissue, Other and unspecified

+∞

22.9

Z3231

NOMESCO Finland

Registered nurse

1.6

22.9

622

4226

N02BE01

ATC

paracetamol; systemic, rectal

1.9

22.7

2067

18690

L20

ICPC

Joint symptom/complaint NOS

2.9

22.6

110

395

R53

ICD-10 Finland

Malaise and fatigue

1.7

22.5

563

3745

A01AB09

ATC

miconazole; local oral

2.1

22.3

227

1140

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.9

22.3

296

1634

L95

ICPC

Osteoporosis

2.8

22.1

114

422

K07.60

ICD-10 Finland

Snapping jaw

2.4

22.0

159

694

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

21.9

452

2853

TNG10

NOMESCO Finland

Puncture of knee

5.1

21.9

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.1

21.8

320

N02BF01

ATC

gabapentin; oral

2.1

21.8

220

1102

R03AC02

ATC

salbutamol; inhalant

1.5

21.6

1297

10514

R1250

NOMESCO Finland

Evaluation of functional capability

3.6

21.5

201

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

21.4

624

4303

S18

ICPC

Laceration/cut

1.5

21.2

994

7631

J01DA01

ATC

[U] cefalexin

1.5

21.2

1436

11923

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

21.1

339

1987

A02BA02

ATC

ranitidine; systemic

1.7

21.0

447

2843

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

20.9

215

1083

1XC02, ,

NOMESCO Finland

7.1

20.8

J01AA02

ATC

doxycycline; systemic

1.6

20.7

1807

15836

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

20.7

324

1884

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.1

20.6

293

R4110

NOMESCO Finland

Physiotherapy

1.6

20.6

628

4371

M31.3

ICD-10 Finland

Wegener granulomatosis

211.8

20.6

5BA08, ,

NOMESCO Finland

8.3

20.5

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

17.1

20.5

D07AC01

ATC

betamethasone; topical

1.5

20.4

813

6012

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.5

20.4

130

535

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

5.0

20.4

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.8

20.2

100

362

L50.9

ICD-10 Finland

Urticaria, unspecified

2.7

20.0

107

404

M54.5

ICD-10 Finland

Low back pain

1.5

19.9

838

6263

Z3226

NOMESCO Finland

Physiotherapist

1.7

19.9

426

2709

7102A

ICD-9 Finland

Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]

+∞

19.8

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

5.1

19.8

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.8

19.6

157

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

201.6

19.6

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.1

19.5

276

R52.9

ICD-10 Finland

Pain, unspecified

2.0

19.5

233

1239

M05BA06

ATC

ibandronic acid; systemic

3.4

19.5

210

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.1

19.5

207

1056

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.0

19.1

204

1042

K11.70

ICD-10 Finland

Hypoptyalism

7.0

19.1

A01

ICPC

Pain general/multiple sites

2.0

19.0

227

1206

M01AX01

ATC

nabumetone; oral

2.6

19.0

114

456

L04AB01

ATC

etanercept; parenteral

4.0

19.0

138

J05AB11

ATC

valaciclovir; oral

1.7

19.0

354

2166

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

18.8

170

815

286

Kela drug reimbursment

Ciclosporin eye drop

+∞

18.8

E000001, ,

ATC

1.6

18.7

459

3020

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

18.7

248

1366

TAB00

NOMESCO Finland

Lumbar puncture

2.5

18.7

120

496

A02BX02

ATC

sucralfate; oral

2.6

18.6

107

419

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

6.1

18.6

B01AB05

ATC

enoxaparin; parenteral

1.5

18.5

702

5116

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

18.4

606

4278

M01CB03

ATC

auranofin; oral

5.9

18.4

A05AA02

ATC

ursodeoxycholic acid; oral

3.7

18.4

155

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.6

18.4

107

422

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.8

18.3

151

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

7.5

18.2

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

18.2

179

887

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

18.2

341

2088

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.2

18.2

166

799

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

18.1

170

827

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.2

18.1

150

694

B02.9

ICD-10 Finland

Zoster without complication

2.2

18.0

163

781

R00.2

ICD-10 Finland

Palpitations

2.0

17.9

207

1087

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.6

17.9

105

416

L01AA01

ATC

cyclophosphamide; systemic

16.7

17.9

J05AB01

ATC

aciclovir; systemic

1.6

17.6

534

3693

G73.7

ICD-10 Finland

Myopathy in other diseases classified elsewhere

181.3

17.5

L94.0

ICD-10 Finland

Localized scleroderma [morphea]

7.8

17.4

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

17.3

408

2654

ELB10

NOMESCO Finland

Excision of minor salivary gland

21.0

17.3

XF404

NOMESCO Finland

Ambulatory ECG

2.0

17.3

193

1002

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

17.3

189

974

Z2221

NOMESCO Finland

Medical doctor

1.5

17.2

630

4540

ZXA00

NOMESCO Finland

Right side

1.6

17.1

569

4014

N02AA05

ATC

oxycodone; systemic

1.7

17.1

363

2297

S97

ICPC

Chronic ulcer skin

2.3

17.0

128

568

SPAT1229

SPAT

Assessment of need for aid

2.1

17.0

173

867

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

16.9

326

2009

M13.0

ICD-10 Finland

Polyarthritis, unspecified

4.3

16.9

101

A02BA04

ATC

nizatidine; systemic

2.1

16.9

175

884

M01CB01

ATC

sodium aurothiomalate; parenteral

4.0

16.8

123

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

16.8

254

1458

UJF92

NOMESCO Finland

Capsular endoscopy

3.4

16.7

180

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.1

16.7

157

764

A01AB04

ATC

amphotericin B; local oral

2.4

16.7

119

516

XQ860

NOMESCO Finland

Laser Doppler measurement/scan of capillary perfusion

+∞

16.7

J99.1*M35.0

ICD-10 Finland

Respiratory disorders in sicca syndrome [Sjögren]

+∞

16.7

N02AC04

ATC

dextropropoxyphene; oral

2.7

16.7

336

M01AB55

ATC

diclofenac, combinations; oral

2.1

16.6

164

813

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

16.6

394

2565

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.2

16.6

201

N02BF02

ATC

pregabalin; oral

2.2

16.5

149

713

M05BA01

ATC

etidronic acid; systemic

7.3

16.5

L17

ICPC

Foot/toe symptom/complaint

1.5

16.5

638

4645

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

171.2

16.5

R52.2

ICD-10 Finland

Other chronic pain

2.5

16.4

102

415

XA402

NOMESCO Finland

ENMG

3.1

16.4

223

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

16.2

334

2096

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

4.4

16.2

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

16.0

358

2293

G72.9

ICD-10 Finland

Myopathy, unspecified

5.7

15.9

R13

ICD-10 Finland

Dysphagia

2.1

15.8

163

821

R60.0

ICD-10 Finland

Localized oedema

1.8

15.8

262

1546

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

+∞

15.6

M34

ICD-10 Finland

Systemic sclerosis

+∞

15.6

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

3.4

15.6

173

WX203

NOMESCO Finland

Infraclavicular plexus blockade

3.1

15.6

214

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

6.1

15.6

R76.0

ICD-10 Finland

Raised antibody titre

13.8

15.5

J01EA01

ATC

trimethoprim; systemic

1.5

15.5

642

4732

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.3

15.5

184

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

4.7

15.4

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

5.5

15.2

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

15.2

259

1538

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

15.2

435

2957

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.7

15.2

317

Z2446

NOMESCO Finland

Social worker

2.1

15.1

154

773

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

15.0

231

1332

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

15.0

336

2152

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

15.0

249

1469

T78.4

ICD-10 Finland

Allergy, unspecified

2.3

14.9

120

549

J01FA10

ATC

azithromycin; systemic

1.4

14.9

1318

11154

M25.9

ICD-10 Finland

Joint disorder, unspecified

4.2

14.9

A46

ICD-10 Finland

Erysipelas

1.7

14.8

277

1689

XF402

NOMESCO Finland

ECG with work load test

1.8

14.8

217

1232

JN4BD

NOMESCO Finland

Extensive body CT

1.8

14.8

217

1233

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.9

14.8

183

984

SAA04

NOMESCO Finland

Special examination of mouth

2.2

14.8

124

577

R05

ICD-10 Finland

Cough

1.5

14.7

478

3341

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

2.0

14.7

162

837

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

14.7

392

2621

Z50.1

ICD-10 Finland

Other physical therapy

2.2

14.5

128

608

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

4.8

14.5

E000006, ,

ATC

2.0

14.5

164

855

R07.3

ICD-10 Finland

Other chest pain

1.8

14.5

231

1346

C02KX01

ATC

bosentan; oral

150.9

14.5

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

150.9

14.5

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

4.0

14.4

105

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.6

14.4

326

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

5.6

14.3

Z01.9

ICD-10 Finland

Special examination, unspecified

2.1

14.3

138

679

N03AE01

ATC

clonazepam; systemic

2.1

14.3

134

652

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

14.3

406

2754

AN1

Coronary angiography

1.9

14.2

194

1077

RT271, ,

NOMESCO Finland

22.4

14.2

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

14.2

833

6539

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

5.7

14.1

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

14.1

769

5952

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.8

14.1

209

1190

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.1

14.1

190

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

14.1

185

1015

B07.9

ICD-10 Finland

Verruca simplex

2.5

14.1

348

P01AB01

ATC

metronidazole; oral, rectal

1.4

14.0

931

7466

RT272, ,

NOMESCO Finland

10.9

14.0

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.3

14.0

155

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.6

13.9

131

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

13.9

113

519

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

13.9

337

2199

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.2

13.9

R03AC03

ATC

terbutaline; inhalant

1.6

13.9

321

2070

D07AB08

ATC

desonide; topical

1.7

13.8

242

1448

M06

ICD-10 Finland

Other rheumatoid arthritis

5.6

13.8

I27.0

ICD-10 Finland

Primary pulmonary hypertension

17.6

13.8

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

13.8

281

1754

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.2

13.8

113

521

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.0

13.8

203

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

4.7

13.8

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

13.7

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

13.7

258

1576

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.1

13.6

178

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

13.6

1088

8990

M30.0

ICD-10 Finland

Polyarteritis nodosa

+∞

13.6

J99.1*M34.8

ICD-10 Finland

Respiratory disorders in systemic: sclerosis

+∞

13.6

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

4.6

13.5

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

13.5

345

2278

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

13.5

1140

9499

C02KX04

ATC

macitentan; oral

34.2

13.5

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

13.5

643

4848

R4190

NOMESCO Finland

Nutritional therapy

2.5

13.5

349

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

3.7

13.5

115

M35.4

ICD-10 Finland

Diffuse (eosinophilic) fasciitis

140.8

13.5

SPAT1255

SPAT

Intravenous administration of medicine

2.0

13.4

145

744

A12BA01

ATC

potassium chloride; oral

2.4

13.4

393

I77.6

ICD-10 Finland

Arteritis, unspecified

25.9

13.4

A03FA02

ATC

cisapride; oral, rectal

1.9

13.3

171

931

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

6.3

13.3

UKC02

NOMESCO Finland

Cystoscopy

1.7

13.3

275

1724

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

5.4

13.2

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

13.2

433

3025

ZXA05

NOMESCO Finland

Left side

1.5

13.2

514

3722

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.0

13.2

138

699

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

13.2

186

1044

XQ848

NOMESCO Finland

Dermatological photography

2.7

13.1

265

AA1AD

NOMESCO Finland

CT of head and brain

1.5

13.1

533

3895

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

13.1

379

Z01.2

ICD-10 Finland

Dental examination

1.4

13.0

992

8109

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.7

13.0

266

J45.8

ICD-10 Finland

Mixed asthma

2.6

13.0

307

WW200

NOMESCO Finland

Immunization

2.8

13.0

238

L12

ICPC

Hand/finger symptom/complaint

1.6

13.0

359

2416

D07AD01

ATC

clobetasol; topical

1.6

12.9

371

2520

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

4.9

12.8

B01AA03

ATC

warfarin; systemic

1.6

12.8

319

2092

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

12.8

566

4202

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

12.7

155

829

XG460

NOMESCO Finland

Short time oxymetry

3.5

12.7

120

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.2

12.7

102

467

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

12.6

188

1072

NHQ40

NOMESCO Finland

Amputation of toe

4.0

12.6

RS221, ,

NOMESCO Finland

3.6

12.6

111

R03BA08

ATC

ciclesonide; inhalant

1.8

12.6

210

1239

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

12.6

346

2324

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.3

12.5

424

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

12.5

235

1433

K76.9

ICD-10 Finland

Liver disease, unspecified

3.5

12.5

121

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

12.5

289

1861

G05.8*M32.1

ICD-10 Finland

Encephalitis in systemic lupus erythematosus

+∞

12.5

M35.2

ICD-10 Finland

Behçet disease

+∞

12.5

J01CA04

ATC

amoxicillin; systemic

1.5

12.5

1829

16633

SPAT1301

SPAT

No procedures

1.4

12.5

640

4881

M31.1

ICD-10 Finland

Thrombotic microangiopathy

130.7

12.4

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

12.4

322

2133

R02

ICPC

Shortness of breath/dyspnoea

1.7

12.4

268

1698

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

12.3

194

1125

M01AX17

ATC

nimesulide; oral

1.5

12.3

517

3796

ZX108

NOMESCO Finland

Inhalation

5.4

12.3

G44.2

ICD-10 Finland

Tension-type headache

1.6

12.3

325

2162

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

12.3

272

1733

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

12.3

117

573

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.9

12.2

155

840

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.7

12.2

104

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

12.2

241

1490

A03

ICPC

Fever

1.6

12.2

353

2397

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.6

12.2

287

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

12.2

899

7289

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

12.1

378

2610

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

12.1

231

1415

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.0

12.1

125

631

WX002

NOMESCO Finland

Sedation and analgesia

1.5

12.1

405

2839

M01AH05

ATC

etoricoxib; oral

1.4

12.1

1375

11934

C03DA01

ATC

spironolactone; oral

1.7

12.1

230

1409

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.5

12.0

295

NH3AE

NOMESCO Finland

Feet ultrasound examination

9.3

12.0

SBB10

NOMESCO Finland

Dental impressions

1.9

12.0

144

767

A41.9

ICD-10 Finland

Sepsis, unspecified

2.5

11.9

296

A07EA06

ATC

budesonide; oral, local oral

2.3

11.9

370

L04AB04

ATC

adalimumab; parenteral

2.8

11.9

215

M01AE02

ATC

naproxen; oral, rectal

1.4

11.8

1256

10767

R11

ICD-10 Finland

Nausea and vomiting

1.8

11.7

194

1142

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

11.7

530

3944

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

11.7

486

3558

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

11.7

191

1121

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

11.6

197

1168

L94.9

ICD-10 Finland

Localized connective tissue disorder, unspecified

65.3

11.6

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.9

11.6

153

841

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.4

11.6

325

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

11.5

151

827

EBA10

NOMESCO Finland

Operative extraction of tooth

1.7

11.5

245

1544

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.4

11.5

313

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

11.1

11.5

D02AE01

ATC

carbamide; topical

1.9

11.5

144

777

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.3

11.5

128

D02AX

ATC

Other emollients and protectives

2.4

11.5

326

7102B

ICD-9 Finland

Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM SECUNDARIUM]

+∞

11.5

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

11.5

135

714

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.4

11.5

320

N06AB04

ATC

citalopram; systemic

1.5

11.4

460

3344

C07AB02

ATC

metoprolol; systemic

1.5

11.4

389

2734

M45

ICD-10 Finland

Ankylosing spondylitis

2.9

11.4

176

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

11.9

11.3

R76.8

ICD-10 Finland

Other specified abnormal immunological findings in serum

35.2

11.3

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.9

11.2

153

849

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

9.6

11.2

-1, ,

NOMESCO Finland

1.4

11.2

691

5421

RT274, ,

NOMESCO Finland

17.1

11.2

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.5

11.2

275

N07AA02

ATC

pyridostigmine; systemic

5.6

11.2

A28

ICPC

Limited function/disability NOS

1.6

11.1

316

2134

S01KA02

ATC

hypromellose; ophthalmic

2.9

11.1

178

SPAT1263

SPAT

Sampling

1.4

11.1

872

7112

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

11.1

771

6167

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.9

11.0

179

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

3.8

11.0

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

8.6

11.0

ZXA10

NOMESCO Finland

Bilateral

1.5

11.0

382

2694

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

11.0

383

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.2

11.0

137

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

11.0

128

675

R01AD09

ATC

mometasone; nasal

1.3

11.0

1017

8503

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

11.0

170

982

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

3.3

11.0

127

NDL52

NOMESCO Finland

Tenosynovectomy of hand

4.5

11.0

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

10.9

1577

14092

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

10.9

170

983

L93.1

ICD-10 Finland

Subacute cutaneous lupus erythematosus

43.5

10.9

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

10.9

529

3978

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

10.9

229

1439

ZXE00

NOMESCO Finland

One hour or less

1.4

10.9

829

6725

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.2

10.8

128

N05CD07

ATC

temazepam; oral

1.6

10.8

231

1458

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

10.8

475

3509

XKD00

NOMESCO Finland

Uroflowmetry

1.7

10.8

195

1177

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.1

10.8

472

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

10.8

394

2808

ZXD05

NOMESCO Finland

Urgent procedure

1.4

10.8

624

4840

ND1AE

NOMESCO Finland

Wrist ultrasound examination

8.9

10.8

L84

ICD-10 Finland

Corns and callosities

2.3

10.7

355

N06AX11

ATC

mirtazapine; oral

1.4

10.7

728

5793

M48.0

ICD-10 Finland

Spinal stenosis

1.6

10.7

241

1542

M02AA07

ATC

piroxicam; topical

1.4

10.7

755

6048

D01AE16

ATC

amorolfine; topical

1.6

10.6

241

1544

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

10.6

102

502

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

5.3

10.6

R42

ICD-10 Finland

Dizziness and giddiness

1.4

10.5

465

3436

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

10.5

305

2070

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

10.5

1008

8454

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.4

10.5

290

J01DA09

ATC

[U] cefadroxil

1.4

10.4

564

4319

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

+∞

10.4

L87.1

ICD-10 Finland

Reactive perforating collagenosis

+∞

10.4

XQ844

NOMESCO Finland

Other microscope or electron microscope examination

+∞

10.4

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

+∞

10.4

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

10.4

147

826

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

10.4

1553

13892

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

10.3

1449

12829

H03AA01

ATC

levothyroxine sodium; systemic

1.4

10.3

556

4255

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

10.3

166

971

TQW80

NOMESCO Finland

Local dermatologic skincare

2.6

10.2

233

R03DC03

ATC

montelukast; oral

1.5

10.2

374

2665

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

10.1

463

3441

78880

ICD-8 Finland

Other general symptoms, Pyrexia of unknown origin

5.3

10.1

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

10.1

154

885

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.0

10.1

113

588

H16.9

ICD-10 Finland

Keratitis, unspecified

3.1

10.1

134

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

10.1

230

1476

SBA00

NOMESCO Finland

Microbiological examinations

2.5

10.0

235

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

10.0

198

1224

I73.8

ICD-10 Finland

Other specified peripheral vascular diseases

14.6

10.0

L30.8

ICD-10 Finland

Other specified dermatitis

2.4

10.0

272

JN4AD

NOMESCO Finland

Body CT examination

1.7

10.0

187

1140

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

9.9

115

605

A01AB10

ATC

natamycin; local oral

2.4

9.9

298

J47

ICD-10 Finland

Bronchiectasis

2.9

9.9

157

R01AD08

ATC

fluticasone; nasal

1.4

9.9

619

4853

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

8.1

9.8

R05

ICPC

Cough

1.4

9.8

506

3839

N06AX16

ATC

venlafaxine; oral

1.5

9.8

317

2201

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

9.8

201

1256

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.1

9.8

423

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.2

9.7

390

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

9.7

273

1838

J01MA06

ATC

norfloxacin; oral

1.5

9.7

298

2047

N05CF01

ATC

zopiclone; oral

1.4

9.6

667

5307

RJ420, ,

NOMESCO Finland

5.3

9.6

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

9.6

338

2386

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

5.0

9.6

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

9.6

601

4709

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

8.4

9.5

M03BX02

ATC

tizanidine; oral

1.3

9.5

1377

12174

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.2

9.5

361

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

10.1

9.5

L01CB

ATC

Podophyllotoxin derivatives

15.1

9.5

XG405

NOMESCO Finland

Education on PEF monitoring

3.1

9.5

123

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

3.1

9.5

123

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.5

9.5

230

I50.0

ICD-10 Finland

Congestive heart failure

1.9

9.5

117

630

S29

ICPC

Skin symptom/complaint other

1.4

9.4

392

2858

L93.2

ICD-10 Finland

Other local lupus erythematosus

100.4

9.4

J01FA09

ATC

clarithromycin; systemic

1.4

9.4

671

5360

D07AC13

ATC

mometasone; topical

1.4

9.4

598

4693

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.7

9.4

184

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

9.4

113

603

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.5

9.4

225

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

+∞

9.4

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.0

9.4

505

H15.1

ICD-10 Finland

Episcleritis

3.1

9.4

124

R03AK08

ATC

formoterol and beclometasone; inhalant

2.0

9.4

102

526

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.2

9.3

114

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.6

9.3

208

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.3

9.3

300

SPAT1254

SPAT

Administration of medicine

1.5

9.3

281

1923

A06AD11

ATC

lactulose; oral

1.5

9.3

277

1890

XCK00

NOMESCO Finland

Perimetry

1.8

9.2

125

693

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.6

9.2

209

N30.0

ICD-10 Finland

Acute cystitis

1.5

9.2

363

2620

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

9.2

413

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.7

9.1

181

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

9.1

489

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.7

9.1

187

M13.8

ICD-10 Finland

Other specified arthritis

3.6

9.1

N03AF02

ATC

oxcarbazepine; oral

2.2

9.1

322

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.2

9.1

335

K11.9

ICD-10 Finland

Disease of salivary gland, unspecified

4.4

9.1

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

4.6

9.1

C09CA06

ATC

candesartan; oral

1.4

9.1

484

3689

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

9.0

558

4355

J01FA01

ATC

erythromycin; systemic

1.5

9.0

292

2026

M79.3

ICD-10 Finland

Panniculitis, unspecified

10.1

9.0

EKA10

NOMESCO Finland

iopsy of buccal mucosa

2.6

9.0

206

ZZA00

NOMESCO Finland

Split skin graft

2.5

9.0

236

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.7

9.0

149

879

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

9.0

163

986

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

9.0

118

649

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.6

9.0

PJA10

NOMESCO Finland

Exploration of lymph nodes

3.5

8.9

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

3.4

8.9

XCH00

NOMESCO Finland

Eye pressure measurement

2.0

8.8

474

UJD02

NOMESCO Finland

Gastroscopy

2.0

8.8

509

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.9

8.8

145

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

3.1

8.8

113

SXC03

NOMESCO Finland

Other oral or dental procedure

3.5

8.8

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.1

8.8

420

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

4.0

8.8

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

8.8

586

4626

N91.1

ICD-10 Finland

Secondary amenorrhoea

3.0

8.8

129

6BA02, ,

NOMESCO Finland

9.5

8.8

SPAT1153

SPAT

Removal of sutures

1.3

8.7

621

4949

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

8.7

687

5558

C01DA14

ATC

isosorbide mononitrate; oral

1.5

8.7

240

1608

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.2

8.7

322

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

8.7

603

4788

K11.7

ICD-10 Finland

Disturbances of salivary secretion

14.1

8.7

NG1DA

NOMESCO Finland

X-ray of knees

2.7

8.7

163

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.4

8.7

234

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.0

8.7

130

L04AD02

ATC

tacrolimus; systemic

4.3

8.7

SFA10

NOMESCO Finland

One-surface restoration

1.3

8.6

1156

10057

ZY010

NOMESCO Finland

Hospital outpatient

1.9

8.6

108

585

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

4.1

8.5

M12.3

ICD-10 Finland

Palindromic rheumatism

10.1

8.5

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.9

8.5

523

R4180

NOMESCO Finland

Podiatric therapy

3.3

8.5

Z71.8

ICD-10 Finland

Other specified counselling

1.3

8.5

643

5171

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

20.1

8.5

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.1

8.4

386

A06AC51

ATC

ispaghula, combinations; oral

1.9

8.4

103

553

4430A

ICD-9 Finland

Other peripheral vascular disease, Raynaud's syndrome

90.4

8.4

A08

ICPC

Swelling

1.9

8.4

103

554

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.9

8.4

138

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.9

8.4

102

547

M19.2

ICD-10 Finland

Other secondary arthrosis

3.1

8.4

106

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.1

8.4

106

N08.5*M31.7

ICD-10 Finland

Glomerular disease states in microscopic polyangiitis

+∞

8.3

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

+∞

8.3

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.0

8.3

B01AC04

ATC

clopidogrel; oral

1.5

8.3

263

1815

R03BB04

ATC

tiotropium bromide; inhalant

1.6

8.3

183

1163

B35.3

ICD-10 Finland

Tinea pedis

2.0

8.3

436

WX892

NOMESCO Finland

Monitored bed care

1.7

8.3

138

815

L50.0

ICD-10 Finland

Allergic urticaria

2.3

8.2

284

K29

ICPC

Cardiovascular sympt/complt other

2.1

8.2

383

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

8.2

122

697

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

8.2

578

4594

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.7

8.2

157

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

7.5

8.2

R52.1

ICD-10 Finland

Chronic intractable pain

3.6

8.1

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.6

8.1

NG2CA

NOMESCO Finland

X-ray of patella with specialised projection

4.6

8.1

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

8.1

507

3956

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

17.2

8.1

XA800

NOMESCO Finland

Neuropsychological investigation

2.0

8.1

427

RT171, ,

NOMESCO Finland

11.7

8.1

QDH05

NOMESCO Finland

Correction of deformity of toe nail

11.7

8.1

XG466

NOMESCO Finland

Sleep oxymetry

2.3

8.1

261

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

8.1

168

1054

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.4

8.1

236

WZC30

NOMESCO Finland

Teaching

1.5

8.0

307

2200

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.3

8.0

249

SFA30

NOMESCO Finland

Three-surface restoration

1.3

8.0

869

7331

B34.9

ICD-10 Finland

Viral infection, unspecified

2.3

8.0

262

ZX100

NOMESCO Finland

Oral

3.1

8.0

104

L50.1

ICD-10 Finland

Idiopathic urticaria

3.9

8.0

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

8.0

121

696

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

7.2

8.0

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

7.2

8.0

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.4

7.9

225

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

4.4

7.9

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

7.9

105

580

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.0

7.9

410

C02DE02, ,

ATC

3.6

7.8

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.7

7.8

149

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

7.8

128

752

K02.1

ICD-10 Finland

Caries of dentine

1.3

7.8

1225

10813

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

7.8

143

867

A02BA03

ATC

famotidine; systemic

2.1

7.8

357

S06.0

ICD-10 Finland

Concussion

1.6

7.8

201

1327

C08DB01

ATC

diltiazem; oral

1.9

7.8

503

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

3.3

7.8

SPAT1325

SPAT

Vaccination

1.3

7.8

644

5233

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

7.8

116

664

U07

ICPC

Urine symptom/complaint other

1.7

7.8

146

892

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

7.8

249

1724

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

7.7

526

M05.2

ICD-10 Finland

Rheumatoid vasculitis

45.1

7.7

7199L

ICD-9 Finland

Other and unspecified disorder of joint, Unspecified disorder of joint[MB ARTICULI NUD,USEAT NIVELET]

15.1

7.7

Z94.2

ICD-10 Finland

Lung transplant status

15.1

7.7

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

6.4

7.7

G62.8

ICD-10 Finland

Other specified polyneuropathies

3.9

7.7

SFA00

NOMESCO Finland

Small restoration

1.5

7.7

283

2014

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.6

7.7

174

J98.1

ICD-10 Finland

Pulmonary collapse

4.5

7.6

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.4

7.6

223

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.7

7.6

140

N18.0

ICD-10 Finland

End-stage renal disease

4.0

7.6

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

4.0

7.6

XQ802

NOMESCO Finland

Epicutan test

1.9

7.6

493

104

Kela drug reimbursment

Thyroid insufficiency

1.6

7.6

164

1038

N35.0

ICD-10 Finland

Post-traumatic urethral stricture

18.4

7.6

R50.1

ICD-10 Finland

Persistent fever

25.1

7.6

H01

ICPC

Ear pain/earache

1.5

7.6

235

1616

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

7.6

115

662

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

7.6

133

798

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

7.5

116

670

127

Kela drug reimbursment

Transplant complication

3.2

7.5

H11.1

ICD-10 Finland

Conjunctival degenerations and deposits

4.1

7.5

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.4

7.5

219

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

4.2

7.5

R06.4

ICD-10 Finland

Hyperventilation

2.8

7.4

125

DHA10

NOMESCO Finland

Biopsy of cavity of nose

3.9

7.4

NJ3DG

NOMESCO Finland

Very extensive MRI examination of extremities with high intensity magnet

80.3

7.4

ACC51

NOMESCO Finland

Release of median nerve

1.6

7.4

159

1005

SPAT1252

SPAT

Overall medication plan or its review

1.7

7.4

123

727

R35

ICD-10 Finland

Polyuria

1.8

7.4

113

652

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.2

7.4

291

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

6.0

7.4

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.4

7.4

202

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

2.6

7.4

160

L29.9

ICD-10 Finland

Pruritus, unspecified

2.1

7.3

305

G47.3

ICD-10 Finland

Sleep apnoea

1.4

7.3

397

3024

R03BA05

ATC

fluticasone; inhalant

1.4

7.3

373

2813

NC1CG

NOMESCO Finland

Elbow and forearm extensive MRI examination with high intensity magnet

8.4

7.3

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

8.4

7.3

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

3.6

7.3

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.6

7.3

G73.7*M32.1

ICD-10 Finland

Myopathy in systemic lupus erythematosus

+∞

7.3

N16.4*M35.0

ICD-10 Finland

Sjögren's syndrome with renal tubulo-interstitial disorders

+∞

7.3

M31.0

ICD-10 Finland

Hypersensitivity angiitis

+∞

7.3

J99.1*M33.2

ICD-10 Finland

Respiratory disorders in polymyositis

+∞

7.3

RT350, ,

NOMESCO Finland

10.9

7.3

I34.1

ICD-10 Finland

Mitral (valve) prolapse

2.4

7.3

203

L95.8

ICD-10 Finland

Other vasculitis limited to skin

9.4

7.3

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

9.4

7.3

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.3

7.3

222

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

7.2

1158

10209

M05.3

ICD-10 Finland

Rheumatoid arthritis with involvement of other organs and systems

15.8

7.2

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

7.2

389

2960

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

4.3

7.2

M02AA10

ATC

ketoprofen; topical

1.4

7.2

315

2314

KMAK, ,

NOMESCO Finland

1.3

7.2

1078

9430

G03DB01

ATC

dydrogesterone; oral

1.4

7.2

308

2255

R28

ICPC

Limited function/disability (R)

3.1

7.2

N03AF01

ATC

carbamazepine; oral, rectal

1.8

7.2

547

GDG10

NOMESCO Finland

Bilateral transplantation of lung

20.1

7.1

RT160, ,

NOMESCO Finland

20.1

7.1

T93.2

ICD-10 Finland

Sequelae of other fractures of lower limb

3.5

7.1

K29.7

ICD-10 Finland

Gastritis, unspecified

2.0

7.1

363

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

2.8

7.1

117

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

7.1

221

1520

R01AD12

ATC

fluticasone furoate; nasal

1.3

7.1

676

5586

R03BB01

ATC

ipratropium bromide; inhalant

2.0

7.1

343

F48.0

ICD-10 Finland

Neurasthenia

12.1

7.1

K12.00

ICD-10 Finland

Recurrent oral aphthae

2.8

7.1

123

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

7.1

463

3632

J01DA06

ATC

[U] cefuroxime

1.4

7.0

291

2115

K75.4

ICD-10 Finland

Autoimmune hepatitis

8.8

7.0

NB1AD

NOMESCO Finland

Shoulder CT examination

2.6

7.0

152

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

7.0

275

1979

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

10.0

7.0

L71.8

ICD-10 Finland

Other rosacea

2.5

7.0

164

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.9

7.0

107

EB1WA, ,

NOMESCO Finland

4.2

7.0

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

7.0

571

4620

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.9

7.0

421

XX1VW

NOMESCO Finland

Written report from radiologist

3.5

7.0

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.9

7.0

457

D07AA02

ATC

hydrocortisone; topical

1.4

7.0

270

1939

G04AC01, ,

ATC

2.0

7.0

352

3AC01, ,

NOMESCO Finland

3.4

7.0

SFA20

NOMESCO Finland

Two-surface restoration

1.3

7.0

1233

10983

NBB20

NOMESCO Finland

Primary total prosthetic replacement of humero-scapular joint

3.0

6.9

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

6.9

205

1396

RT172, ,

NOMESCO Finland

13.8

6.9

XF622

NOMESCO Finland

Measurement of minute volume of heart

13.8

6.9

R04.2

ICD-10 Finland

Haemoptysis

2.2

6.9

273

WVA20

NOMESCO Finland

Medicine administration

2.3

6.9

234

D06BX01

ATC

metronidazole; topical

1.5

6.9

237

1665

L01

ICPC

Neck symptom/complaint

1.4

6.9

329

2455

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.8

6.8

540

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

3.2

6.8

KCV04

NOMESCO Finland

Distension of bladder with fluid

3.5

6.8

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.7

6.8

131

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.3

6.8

222

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

6.8

139

868

ULC02

NOMESCO Finland

Hysteroscopy

1.7

6.8

118

706

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

6.8

168

1099

M54.8

ICD-10 Finland

Other dorsalgia

1.8

6.8

534

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

6.8

190

1278

H19.3

ICD-10 Finland

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

11.0

6.8

RD210, ,

NOMESCO Finland

2.6

6.8

143

A11CC03

ATC

alfacalcidol; systemic

2.4

6.8

185

N06AG02

ATC

moclobemide; oral

1.9

6.8

476

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.6

6.8

149

NHK99

NOMESCO Finland

Other operation on bone of ankle or foot

2.4

6.8

179

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

6.8

475

3761

R07.1

ICD-10 Finland

Chest pain on breathing

2.7

6.8

126

B01AC27

ATC

selexipag; oral

40.2

6.8

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

16.7

6.7

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

6.7

118

708

E000007, ,

ATC

1.7

6.7

111

655

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

6.7

240

1697

R03BA01

ATC

beclometasone; inhalant

1.4

6.7

281

2047

N05BA01

ATC

diazepam; systemic, rectal

1.4

6.7

255

1825

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

3.9

6.7

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.9

6.7

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

7.2

6.7

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

7.2

6.7

NDG76

NOMESCO Finland

Fusion of DIP joint

3.4

6.7

WX202

NOMESCO Finland

Supraclavicular plexus blockade

2.8

6.7

110

M06.1

ICD-10 Finland

Adult-onset Still disease

22.6

6.7

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

6.7

1134

10033

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

6.7

130

803

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.2

6.7

231

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

6.7

652

5401

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.0

6.6

324

XQ800

NOMESCO Finland

Prick test

1.6

6.6

157

1017

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.1

6.6

271

K22.1

ICD-10 Finland

Ulcer of oesophagus

2.8

6.6

111

L03

ICPC

Low back symptom/complaint

1.3

6.6

569

4636

R50.0

ICD-10 Finland

Fever with chills

12.3

6.6

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.8

6.6

525

R06AX22

ATC

ebastine; oral

1.4

6.6

371

2843

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.9

6.6

431

N35.8

ICD-10 Finland

Other urethral stricture

8.7

6.5

N04BC05

ATC

pramipexole; oral

1.6

6.5

150

965

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

2.4

6.5

170

R03DC01

ATC

zafirlukast; oral

2.6

6.5

146

K07

ICPC

Swollen ankles/oedema

1.8

6.5

468

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.3

6.5

195

H93.1

ICD-10 Finland

Tinnitus

1.6

6.5

132

824

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

6.5

447

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.7

6.5

122

747

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

6.5

193

1317

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.4

6.5

302

2243

F45.0

ICD-10 Finland

Somatization disorder

5.3

6.5

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

2.4

6.5

171

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

5.7

6.4

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

5.7

6.4

S76

ICPC

Skin infection other

1.8

6.4

573

R81

ICPC

Pneumonia

2.0

6.4

335

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

6.4

238

1695

C02KX02

ATC

ambrisentan; oral

70.0

6.4

M54.2

ICD-10 Finland

Cervicalgia

1.6

6.4

164

1082

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

7.4

6.4

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

6.4

133

835

A04

ICPC

Weakness/tiredness general

1.4

6.4

283

2082

78890

ICD-8 Finland

Other general symptoms, Hypersedimentatio

14.3

6.4

M17.5

ICD-10 Finland

Other secondary gonarthrosis

2.6

6.4

130

R63.4

ICD-10 Finland

Abnormal weight loss

2.0

6.4

364

H57.1

ICD-10 Finland

Ocular pain

1.9

6.4

421

N03AX11

ATC

topiramate; oral

2.1

6.3

269

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

6.3

240

1717

S22

ICPC

Nail symptom/complaint

1.6

6.3

126

783

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.8

6.3

480

H02AA02

ATC

fludrocortisone; oral

3.6

6.3

KDV12

NOMESCO Finland

Urethroscopic internal urethrotomy

5.5

6.3

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

2.0

6.3

324

S32.7

ICD-10 Finland

Multiple fractures of lumbar spine and pelvis

3.5

6.3

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

6.3

463

3689

X57

ICD-10 Finland

Unspecified privation

2.3

6.3

192

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

3.4

6.3

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.0

6.3

N06AB06

ATC

sertraline; oral

1.4

6.3

231

1644

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.8

6.3

445

N16.4*M32.1

ICD-10 Finland

Renal tubulo-interstitial disorders in systemic lupus erythematosus

+∞

6.3

J99.1*M33.9

ICD-10 Finland

Respiratory disorders in dermatopolymyositis

+∞

6.3

N08.5*M31.0

ICD-10 Finland

Glomerular disorders in Goodpasture's syndrome

+∞

6.3

D84.19

ICD-10 Finland

Unspecified defect in the complement system

+∞

6.3

73490

ICD-8 Finland

Diffuse diseases of connective tissue, Keratonconjunctivitis sicca

+∞

6.3

SPAT1260

SPAT

Consultation of another employee

1.4

6.2

330

2501

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

6.2

150

976

H16.0

ICD-10 Finland

Corneal ulcer

1.8

6.2

534

108

Kela drug reimbursment

Myasthenia gravis

7.0

6.2

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

6.2

505

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

6.2

461

L29

ICPC

Musculoskeletal sympt/complt other

1.5

6.2

170

1140

R06AX27

ATC

desloratadine; oral

1.3

6.2

608

5032

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

4.0

6.2

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.1

6.2

252

S80.0

ICD-10 Finland

Contusion of knee

1.6

6.2

151

987

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

6.1

131

828

G50.1

ICD-10 Finland

Atypical facial pain

2.4

6.1

175

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

3.2

6.1

K92.1

ICD-10 Finland

Melaena

1.8

6.1

514

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

5.7

6.1

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

6.1

131

829

129

Kela drug reimbursment

Idiopathic thrombocytopaenia or granulocytopenia

7.7

6.1

R30.0

ICD-10 Finland

Dysuria

1.8

6.1

456

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

6.1

169

1135

SPAT1104

SPAT

Monitoring of emergency patient

1.6

6.1

122

759

SXA10

NOMESCO Finland

Oral mucosal sampling

2.9

6.1

R49.01

ICD-10 Finland

Functional dysphonia

1.9

6.1

370

R80

ICD-10 Finland

Isolated proteinuria

3.8

6.1

NDM99

NOMESCO Finland

Other operation on fascia, ganglion, synovial sheath or bursa of wrist or hand

4.1

6.1

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

4.1

6.1

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

6.1

137

878

L43.8

ICD-10 Finland

Other lichen planus

2.4

6.1

176

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.0

6.1

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.9

6.1

399

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.0

6.0

315

R5110, ,

SPAT

1.6

6.0

121

753

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.9

6.0

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

6.0

557

4570

R15

ICD-10 Finland

Faecal incontinence

2.0

6.0

336

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

3.6

6.0

J96.1

ICD-10 Finland

Chronic respiratory failure

2.5

6.0

146

R03AK11

ATC

formoterol and fluticasone; inhalant

2.1

6.0

261

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.2

6.0

215

C07AB12

ATC

nebivolol; oral

2.0

6.0

302

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.0

6.0

302

K13.78

ICD-10 Finland

Other change in the oral mucosa

2.1

6.0

248

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.9

6.0

372

C01CA24

ATC

epinephrine; parenteral

1.6

6.0

133

849

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40760892) CBC W Ordered Manual Differential panel - Blood

1847

8878

6.24

321.91

11.9

5.9

—

(3005719) IgG [Mass/volume] in Serum or Plasma

641

1323

6.31

310.88

3.6

2.6

11.44

10.43

g/l

5.10

611

1191

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

268

109

27.66

307.65

1.4

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

265

108

27.56

307.65

1.4

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

689

390

24.68

307.65

1.8

1.1

9.65

2.15

u/ml

2.19

161

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

561

337

21.62

307.65

1.7

1.1

60.04

17.42

u/ml

5.27

131

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

268

109

27.66

307.65

1.4

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

755

499

21.92

307.65

3.5

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

304

183

18.96

307.65

3.1

1.1

35.94

25.60

iu/ml

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

714

667

15.00

307.65

1.7

1.2

4.40

1.01

u/ml

2.54

(3039162) Centromere protein B Ab [Units/volume] in Serum

421

168

30.37

307.65

1.7

1.1

68.26

50.42

u/ml

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

265

108

27.56

307.65

1.4

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

265

108

27.56

307.65

1.4

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

268

109

27.66

307.65

1.4

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

894

443

32.15

307.65

3.4

1.2

0.20

0.25

g/l

21.33

869

417

(3037522) Nuclear Ab [Titer] in Serum

1255

2511

9.68

307.65

2.2

1.3

1087.20

372.37

titre

33.16

689

469

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

707

440

22.64

307.65

1.8

1.1

33.41

6.15

u/ml

4.15

103

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

601

292

27.40

307.65

1.7

1.1

4.11

6.46

u/ml

0.20

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

692

398

24.32

307.65

1.8

1.1

19.26

3.41

u/ml

6.62

259

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

895

466

30.58

307.65

3.4

1.2

1.08

1.22

g/l

15.66

872

438

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

186

37.35

297.74

1.2

1.0

—

(3001604) Monocytes [#/volume] in Blood

1868

9467

5.93

293.12

12.0

5.4

0.55

0.56

e9/l

1.20

1778

8184

(3006315) Basophils [#/volume] in Blood

1870

9492

5.94

292.67

12.1

5.4

0.04

e9/l

1.14

1778

8195

(3013115) Eosinophils [#/volume] in Blood

1889

9869

5.86

279.26

12.4

5.6

0.17

0.19

e9/l

3.55

1811

8658

(3019198) Lymphocytes [#/volume] in Blood

1875

9766

5.74

277.43

12.2

5.5

1.71

1.93

e9/l

13.29

1806

8660

(3009445) Proteinase 3 Ab [Units/volume] in Serum

410

628

7.71

263.63

1.4

1.1

17.07

9.78

u/ml

—

(3004616) Nuclear Ab [Presence] in Serum

241

187

14.26

255.34

1.8

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1939

11125

5.46

233.18

14.7

8.7

3.80

3.99

e9/l

3.72

1844

9704

(3022096) Basophils/100 leukocytes in Blood

1670

8610

4.33

232.31

12.3

5.6

0.72

0.69

1.59

1631

8000

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

340

485

8.04

231.83

1.9

1.4

620.71

295.38

titre

0.65

(3006504) Eosinophils/100 leukocytes in Blood

1691

8897

4.29

225.85

12.4

5.5

2.80

2.82

0.15

1655

8292

(3019069) Monocytes/100 leukocytes in Blood

1694

8952

4.28

224.10

12.9

5.8

8.98

8.35

14.88

1655

8358

(3028026) IgM [Mass/volume] in Serum or Plasma

487

1040

5.66

222.78

1.9

1.8

1.47

1.41

g/l

0.22

459

942

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1243

5393

3.80

219.99

3.3

2.0

134.86

206.30

u/l

2.52

1195

5070

(3018010) Neutrophils/100 leukocytes in Blood

1702

9100

4.24

219.43

12.1

5.4

57.93

56.74

3.90

1662

8514

(3038026) Centromere Ab [Units/volume] in Serum

182

115

17.08

215.24

1.7

1.1

40.24

24.04

u/ml

—

(3002030) Lymphocytes/100 leukocytes in Blood

1704

9226

4.16

212.97

12.6

5.6

27.22

28.60

6.38

1667

8643

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

176

109

17.39

210.21

1.6

1.1

14.24

2.33

u/ml

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

155

17.59

186.84

2.0

1.2

5.70

5.72

u/l

0.01

139

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

907

3498

3.61

186.04

1.5

1.3

40.84

33.14

iu/ml

0.70

391

1131

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

862

3345

3.50

173.05

1.4

1.2

7.86

12.13

u/ml

1.41

338

1322

(3024980) IgG subclass 4 [Mass/volume] in Serum

221

266

9.07

172.34

2.9

1.5

0.94

0.70

g/l

1.37

180

200

(3013707) Erythrocyte sedimentation rate by Westergren method

2068

14441

4.88

145.44

10.6

3.7

14.78

11.89

mm/h

13.90

2028

13375

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1459

8300

3.03

143.52

3.0

2.2

80.75

77.91

nmol/l

3.46

1385

7485

(3024139) IgG subclass 3 [Mass/volume] in Serum

160

161

10.60

142.27

2.4

1.4

0.40

0.39

g/l

0.07

129

112

(3028192) IgG subclass 2 [Mass/volume] in Serum

160

161

10.60

142.27

2.4

1.4

2.85

2.91

g/l

0.11

129

111

(3027135) IgG subclass 1 [Mass/volume] in Serum

160

161

10.60

142.27

2.4

1.4

7.53

6.72

g/l

0.85

127

113

(4062490) Immunoglobulin typing, IgG

161

167

10.28

140.07

2.3

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

178

235

8.12

128.13

1.6

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

193

286

7.27

125.50

1.5

1.2

4.09

4.62

u/ml

0.19

101

111

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

194

290

7.21

125.14

1.5

1.2

3.61

3.65

u/ml

0.01

102

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2041

14766

4.11

121.06

12.7

7.2

74.77

77.64

u/l

2.14

2016

13898

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

28.90

120.70

1.2

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

28.90

120.70

1.2

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

28.90

120.70

1.2

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

28.90

120.70

1.2

1.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1512

9268

2.80

120.40

7.6

6.3

1.22

mmol/l

0.90

1337

7890

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

980

4836

2.77

120.24

3.6

2.9

934.23

1194.66

ng/l

1.90

877

4077

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

259

545

5.22

117.44

1.6

1.5

9.27

0.14

iu/ml

0.49

107

(3037467) Urinalysis macro (dipstick) panel - Urine

1895

13235

3.33

115.85

8.2

4.2

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

152

192

8.40

113.36

2.4

2.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

375

1086

3.92

112.85

1.8

2.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

420

1326

3.64

111.27

2.0

3.0

67.91

66.69

g/l

2.26

395

1205

(3007164) IgA [Mass/volume] in Serum or Plasma

823

3849

2.76

110.29

1.8

1.4

2.48

2.29

g/l

2.11

592

2337

(3035350) Ketones [Presence] in Urine by Test strip

1506

9458

2.68

109.94

6.0

3.6

0.00

estimate

0.12

303

1841

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

18.96

108.46

2.1

1.4

7.57

8.80

ug/l

1.29

(3009261) Glucose [Presence] in Urine by Test strip

1512

9563

2.66

107.94

6.0

3.6

0.00

0.01

estimate

1.32

289

1705

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1376

8377

2.57

105.44

6.7

5.5

1.22

mmol/l

0.96

1303

7620

(3018418) pH of Serum or Plasma

1027

5486

2.56

103.53

4.4

3.8

7.39

7.40

1.21

169

1017

(3021601) Nitrite [Presence] in Urine by Test strip

1490

9469

2.59

103.41

7.9

4.8

0.00

estimate

0.38

294

1735

(3013293) Extractable nuclear Ab [Presence] in Serum

108

141.48

101.98

1.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

285

776

4.05

92.76

1.6

2.0

40.36

39.27

u/l

0.38

259

688

(3017181) Myelocytes/100 leukocytes in Blood

432

1550

3.19

92.16

5.6

3.7

0.79

1.01

1.09

167

484

(3011397) Hemoglobin [Presence] in Urine by Test strip

866

4460

2.50

91.98

5.5

3.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

224

539

4.49

85.72

2.6

2.4

191.37

797.61

ug/l

0.96

208

504

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

473

1857

2.94

85.69

3.2

4.4

240.67

249.96

u/l

0.62

451

1756

(3018095) Leukocytes [#/volume] in Urine

1107

6510

2.34

85.57

5.6

3.4

68.57

96.22

e6/l

0.92

821

4460

(3021440) Promyelocytes/100 leukocytes in Blood

408

1478

3.13

85.18

5.7

3.8

0.03

0.14

5.20

141

411

(3015736) pH of Urine

1237

7639

2.32

85.01

5.2

3.3

5.87

5.86

0.04

622

(3025159) Blasts/100 leukocytes in Blood

386

1393

3.12

80.85

5.8

3.8

0.02

0.60

0.99

116

334

(3000850) Epithelial cells [#/volume] in Urine

737

3768

2.40

77.03

3.6

2.4

4.29

7.18

e6/l

8.75

684

3369

(3021589) Normoblasts [#/volume] in Blood

1308

8521

2.22

75.71

15.4

8.7

0.00

e9/l

0.50

1161

6954

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

201

492

4.38

75.04

1.6

2.1

10.59

11.37

mg/l

0.67

185

451

(3002179) Metamyelocytes/100 leukocytes in Blood

380

1425

2.99

74.02

5.5

3.6

0.35

0.73

4.97

131

415

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

219

582

4.05

73.22

1.7

2.8

11.87

10.09

g/l

4.28

206

520

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

228

634

3.88

71.51

1.7

2.7

3.71

3.58

g/l

0.79

216

576

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

228

635

3.87

71.34

1.7

2.7

7.37

7.35

g/l

0.06

216

576

(3024561) Albumin [Mass/volume] in Serum or Plasma

1243

8074

2.16

70.70

5.8

4.5

35.30

35.81

g/l

2.50

1187

7539

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

227

635

3.85

70.57

1.7

2.7

—

(3002582) Erythrocytes [#/volume] in Urine

933

5435

2.20

70.01

4.5

3.0

75.32

75.52

e6/l

0.00

784

4099

(3022948) Iron [Moles/volume] in Serum or Plasma

577

2803

2.41

66.25

2.7

2.3

12.04

13.31

umol/l

4.29

544

2615

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

215

605

3.81

66.17

1.7

2.8

3.08

2.91

g/l

1.36

203

546

(21491868) Cryoglobulin [Mass/volume] in Serum

11.44

65.90

1.2

0.19

0.43

g/l

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

189

487

4.14

65.77

1.8

2.7

0.03

0.01

g/l

0.24

181

449

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

101

8.59

64.94

1.3

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

189

492

4.09

64.85

1.3

1.2

715.71

947.14

titre

0.22

(40758558) Short blood count panel - Blood

858

4968

2.15

64.09

10.0

6.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

508

2365

2.47

63.83

2.7

2.4

20.79

22.77

2.78

437

2034

(3036481) Cortisol [Moles/volume] in Serum or Plasma

424

1816

2.63

63.46

2.0

2.1

370.89

374.40

nmol/l

0.09

402

1653

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

112

7.93

62.25

1.2

1.1

1.13

1.04

ratio

1.41

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

600

3040

2.31

62.02

3.2

2.5

0.80

1.19

e6/l

3.29

401

1668

(3007566) Smooth muscle Ab [Titer] in Serum

185

490

4.02

61.94

1.3

1.2

95.00

94.67

titre

0.00

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

188

504

3.97

61.90

1.8

2.6

37.28

38.25

g/l

1.17

176

444

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

8.91

61.40

1.2

1.1

12.29

8.27

u/ml

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

818

4721

2.13

60.98

2.9

2.1

2.93

2.96

mg/l

0.14

729

4024

(36304419) Bacteria [Presence] in Urine

842

4916

2.12

60.86

4.2

2.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

807

4638

2.13

60.78

3.0

2.4

2371.76

5342.48

umol/l

1.95

731

4068

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

197

554

3.79

60.58

1.8

2.8

0.69

0.86

g/l

0.24

183

483

(3030467) Casts [#/volume] in Urine by Automated count

850

4998

2.10

60.14

4.5

2.9

0.19

0.41

e6/l

6.02

707

3744

(3004789) Transferrin [Mass/volume] in Serum or Plasma

525

2543

2.37

60.00

2.7

2.3

2.32

2.37

g/l

1.19

498

2356

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

173

453

4.05

58.79

1.8

2.8

0.00

g/l

-0.00

165

417

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

172

449

4.06

58.70

1.9

2.8

0.00

g/l

-0.00

165

417

(3011412) CD3 cells [#/volume] in Blood

155

6.49

58.33

2.1

2.4

1.07

1.17

e9/l

0.47

138

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

117

7.32

56.07

1.3

1.1

187.31

152.00

titre

0.16

(40761535) Cells panel - Urine sediment

357

1501

2.63

54.95

5.5

3.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

180

510

3.74

54.65

2.9

2.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

328

1327

2.71

54.49

2.4

31.45

25.17

au/ml

0.39

113

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

307

1210

2.77

53.62

1.3

29.76

46.15

au/ml

1.27

(3017143) Hepatitis C virus Ab [Presence] in Serum

445

2108

2.37

52.86

1.6

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

326

1359

2.63

50.84

3.4

2.9

159.19

178.88

ng/l

0.39

308

1221

(3042936) Bacteria identified in Isolate by Culture

500

2538

2.24

50.21

2.7

1.9

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1361

9847

1.92

49.92

7.0

6.1

9.71

10.76

umol/l

5.41

1314

9342

(3023368) Bacteria identified in Blood by Culture

765

4569

2.00

49.91

5.5

4.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1241

8799

1.88

47.51

3.6

2.7

112.88

101.85

ug/l

1.08

1174

8196

(3027945) Reticulocytes/100 erythrocytes in Blood

395

1856

2.36

47.39

3.7

2.5

1.70

1.83

1.79

371

1649

(3000475) Leukocytes [#/volume] in Synovial fluid

146

403

3.80

45.94

1.8

1.7

9996.93

11428.55

e6/l

0.19

114

297

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

127

318

4.17

45.74

6.3

5.3

297.77

351.12

iu/ml

0.08

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

206

716

3.06

45.02

2.3

1.8

1.42

1.52

g/l

0.77

187

621

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

106

6.78

44.27

2.0

2.4

423.27

541.89

e6/l

0.61

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

100

6.97

44.19

2.0

2.5

0.18

0.20

e9/l

0.34

(3022217) INR in Platelet poor plasma by Coagulation assay

1158

8154

1.84

44.12

16.7

13.0

1.22

1.20

inr

0.37

345

2380

(3031040) Bacteria [#/volume] in Urine by Automated count

1629

12784

1.91

43.48

6.3

4.4

3695.21

2278.20

e6/l

0.33

167

(3029937) Albumin [Presence] in Urine by Test strip

801

5068

1.89

42.63

7.1

3.9

0.01

0.00

estimate

0.19

295

1711

(3037756) Immunofixation for Serum or Plasma

129

344

3.91

42.61

1.3

1.8

—

(40768443) Skin Pathology biopsy report

221

827

2.85

42.23

1.3

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1056

7298

1.82

42.15

6.5

3.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

151

452

3.50

42.09

1.5

1.3

—

(3019150) Specific gravity of Urine by Refractometry

687

4152

1.93

41.94

6.4

4.0

1.01

1.02

kg/l

1.57

602

(3007853) Bacteria identified in Skin by Aerobe culture

422

2139

2.19

41.82

2.2

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

517

2854

2.04

40.83

2.3

1.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

158

501

3.31

40.20

1.9

4.0

36.04

53.04

mg/l

0.70

130

412

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

105

251

4.33

40.17

2.8

3.0

402.33

1803.88

u/ml

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

9.08

39.90

1.3

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

157

500

3.29

39.66

1.9

4.0

46.51

66.95

mg/l

0.70

130

409

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

728

4553

1.87

39.59

1.4

1.3

2.14

1.58

u/ml

0.43

190

1222

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

130

375

3.61

38.30

1.3

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1077

7639

1.76

38.11

2.1

1.9

99.18

96.94

pmol/l

0.76

564

3826

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

124

5.79

37.92

1.8

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

125

355

3.66

37.69

3.8

3.5

59.62

57.62

0.96

125

355

(3021879) Hepatitis B virus core Ab [Presence] in Serum

300

1374

2.36

37.66

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

683

4245

1.86

37.52

1.6

1.5

20.03

21.24

nmol/l

1.48

605

3639

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

151

486

3.25

37.47

1.9

4.0

1.31

1.75

ratio

0.55

(3029075) Extractable nuclear Ab panel - Serum

9.94

37.47

1.2

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

8.58

37.41

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

119

5.86

37.31

2.0

2.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

977

6821

1.75

35.89

4.4

3.4

26.91

39.60

ng/l

1.25

672

4320

(46235355) HIV 1 and 2 tests - Meaningful Use set

571

3394

1.90

35.79

1.7

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

504

2878

1.96

35.60

1.6

—

(3000494) Fungus identified in Specimen by Culture

417

2236

2.05

35.15

1.9

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2176

19470

2.81

35.10

26.9

12.7

17.86

21.99

mg/l

11.81

1934

15227

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

172

621

2.91

34.98

2.5

1.9

1.88

2.07

ug/l

0.09

149

539

(3015377) Calcium [Moles/volume] in Serum or Plasma

950

6625

1.73

34.71

3.5

3.4

2.34

2.36

mmol/l

3.04

852

5896

(3003458) Phosphate [Moles/volume] in Serum or Plasma

419

2277

2.02

33.94

5.8

5.3

1.05

1.04

mmol/l

0.35

397

2109

(3023520) Reticulocytes [#/volume] in Blood

291

1375

2.28

33.80

2.7

2.5

68.19

71.63

e9/l

0.92

216

1043

(3034426) Prothrombin time (PT)

7.55

32.28

1.3

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

494

2912

1.88

31.25

4.2

3.3

0.81

0.82

mmol/l

1.08

469

2731

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

366

1954

2.04

30.93

2.1

1.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

261

3.79

30.83

2.5

3.4

1.34

1.47

0.16

233

(3005322) IgE [Units/volume] in Serum or Plasma

273

1318

2.21

29.95

1.4

1.2

208.62

183.84

u/ml

0.20

249

1207

(3021788) Differential panel - Synovial fluid

103

301

3.53

29.75

1.4

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

331

1731

2.06

29.51

2.8

2.2

0.21

0.22

g/l

0.09

307

1624

(3013826) Glucose [Moles/volume] in Serum or Plasma

1374

10861

1.65

29.22

5.9

4.4

6.36

6.62

mmol/l

4.72

1315

10127

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

109

335

3.36

29.11

1.8

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

667

4386

1.73

28.95

2.0

1.8

1.08

1.07

mg/l

0.03

524

3335

(3019309) Folate [Moles/volume] in Red Blood Cells

531

3275

1.80

28.75

1.7

1220.23

1183.00

nmol/l

0.43

441

2454

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

841

5895

1.67

28.70

2.9

2.5

59.36

58.66

u/l

0.14

800

5442

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

473

2830

1.84

28.24

3.7

2.6

2.04

3.42

e6/l

3.89

277

1468

(40760888) Immunoglobulin light chains.free panel - Serum

113

363

3.22

28.10

1.9

4.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

887

6337

1.65

27.89

4.3

3.1

32.42

32.99

u/l

0.13

855

6028

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

358

1969

1.97

27.60

2.1

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

421

2463

1.87

26.87

2.2

121.91

119.08

ug/g

0.05

339

1949

(3026782) Osmolality of Urine

557

3574

1.73

25.96

4.2

2.7

503.39

528.33

mosm/kgh2o

2.18

494

3072

(3045414) Leukocytes [Presence] in Urine

200

901

2.33

25.77

2.2

1.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

272

1399

2.07

25.18

8.1

7.2

8.98

9.07

mmol/l

0.09

256

1338

(3026008) Bacteria identified in Urine by Culture

848

6116

1.61

24.94

3.6

3.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

140

4.45

24.61

1.2

—

titre

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

184

830

2.32

23.61

1.1

1.72

0.86

u/ml

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

103

350

3.03

23.31

2.3

2.2

125.13

129.98

g/l

0.96

255

(40768797) Stomach Pathology biopsy report

439

2708

1.77

23.21

1.3

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

100

336

3.06

23.07

1.4

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

7.71

22.96

1.3

1.2

—

(36660697) Celiac disease serology panel - Serum

294

1610

1.95

22.71

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

100

341

3.02

22.49

1.4

1.3

—

17.40

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

7.03

22.49

2.2

2.8

—

(3003396) Base excess in Arterial blood by calculation

337

1942

1.86

22.26

7.9

7.4

1.16

1.13

mmol/l

0.04

275

1533

(3017732) Neutrophils [#/volume] in Blood

257

1354

2.01

22.17

3.5

2.9

3.91

5.17

e9/l

1.48

205

1134

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

525

3445

1.68

22.05

4.7

3.5

266.40

317.18

ng/l

0.29

399

2498

(3030981) Hyaline casts [#/volume] in Urine by Automated count

186

868

2.24

22.00

3.5

2.6

0.14

0.30

e6/l

2.06

179

833

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

337

1950

1.85

21.95

8.0

7.3

5.00

5.09

kpa

0.82

318

1864

(3023419) Bacteria identified in Sputum by Culture

242

3.39

21.94

3.2

2.8

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

430

2677

1.74

21.90

2.4

2.1

29.78

29.37

0.70

420

2601

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

120

4.50

21.77

1.2

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

305

3.10

21.73

1.3

135.53

112.96

u/ml

0.38

(3027801) Oxygen [Partial pressure] in Arterial blood

336

1950

1.85

21.66

8.0

7.3

12.26

12.80

kpa

1.02

318

1864

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

340

2.96

21.39

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1808

15813

1.64

21.30

4.9

4.3

14.82

14.67

pmol/l

1.91

1715

14531

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

247

1305

2.00

21.11

1.8

1.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

158

3.94

21.02

2.3

3.1

57.22

56.81

0.05

136

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

271

1487

1.93

20.74

3.0

2.4

65.24

67.77

ml/min/173m2

0.49

119

593

(3016502) Oxygen saturation in Arterial blood

300

1703

1.87

20.70

8.5

7.9

95.52

95.87

0.50

286

1645

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

314

3.01

20.68

1.3

1.2

304.85

277.69

u/ml

0.19

195

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

109

4.57

20.58

2.4

2.7

43.94

44.13

0.02

(3042631) Mycobacterium sp identified in Specimen

218

3.42

20.44

3.2

2.7

—

(3008898) HLA-B27 [Presence]

160

726

2.29

20.22

1.1

1.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

530

3556

1.64

20.18

2.7

3.0

2.44

2.45

mmol/l

0.61

475

3145

(3008757) Leukocyte morphology finding [Identifier] in Blood

187

3.60

20.02

2.8

3.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

231

3.32

20.01

1.7

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

203

1018

2.09

19.99

5.0

3.3

5.16

5.18

kpa

0.13

198

975

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

110

422

2.69

19.92

1.9

1.5

—

(3044927) Protein electrophoresis panel - Urine

151

3.91

19.86

1.1

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

5.51

19.32

2.2

2.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

130

550

2.44

19.25

1.3

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

707

5128

1.54

19.13

5.6

3.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

199

1010

2.06

18.96

1.7

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

195

3.45

18.81

1.6

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

305

2.92

18.67

1.7

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2023

18394

1.76

18.65

6.0

5.0

1.89

2.04

mu/l

0.67

1931

17001

(3009343) pH of Capillary blood

197

1006

2.05

18.45

5.0

3.3

7.43

7.41

1.74

121

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

129

557

2.39

18.27

1.1

6.59

4.34

u/ml

0.32

(3022621) pH of Urine by Test strip

233

1267

1.93

18.25

3.5

2.9

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

253

1419

1.88

18.03

2.5

2.3

10.82

6.56

ug/l

0.65

215

1242

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

258

1457

1.87

17.99

3.5

80.64

79.93

ng/l

0.06

236

1252

(40768804) Tissue Pathology biopsy report

1041

8268

1.47

17.77

2.3

2.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

190

971

2.04

17.75

4.9

3.3

1.81

1.87

mmol/l

0.08

149

728

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

5.66

17.74

1.1

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

124

536

2.39

17.52

1.4

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

305

2.85

17.50

2.0

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

125

543

2.38

17.47

2.6

2.5

177.09

183.08

0.30

117

520

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

147

3.74

17.39

1.8

1.5

31.96

37.85

0.55

(3044941) Cell count panel - Synovial fluid

268

2.98

17.36

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

122

526

2.39

17.34

2.8

2.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

140

3.78

17.02

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

6.91

16.98

1.3

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

349

2194

1.69

16.82

2.9

2.5

6.26

7.50

umol/l

1.04

305

1893

(3021901) Oxygen saturation in Capillary blood

264

2.94

16.60

4.0

2.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

191

3.31

16.58

1.7

1.6

55.18

58.78

0.26

120

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

182

3.36

16.44

1.7

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

128

577

2.29

16.44

2.4

2.2

98.08

92.02

2.47

123

553

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

102

417

2.51

16.27

1.9

1.5

—

(3019225) pH of Specimen

306

1873

1.73

16.23

4.3

4.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

341

2.67

16.20

1.1

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

653

4794

1.50

16.19

5.2

3.6

93.66

93.48

0.06

635

4674

(3037692) Legionella sp identified in Specimen by Organism specific culture

5.61

16.02

1.7

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

300

2.76

15.74

1.9

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

300

2.76

15.74

1.9

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

256

1506

1.79

15.56

7.4

6.6

1.24

1.33

mmol/l

0.99

250

1471

(3002173) Hemoglobin [Mass/volume] in Arterial blood

268

1604

1.76

15.35

9.1

8.2

119.03

120.38

g/l

0.55

259

1561

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

122

557

2.26

15.21

1.3

—

(3036489) Thrombin time

142

693

2.12

15.00

2.4

2.1

22.31

20.88

1.15

122

608

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.23

14.38

2.2

2.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

4.43

14.27

2.4

3.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

328

2.59

14.23

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

107

476

2.31

14.20

1.8

1.6

—

(3000991) Gas panel - Venous blood

237

1401

1.77

14.14

8.6

7.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

159

3.32

14.11

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

159

3.32

14.11

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

159

3.32

14.11

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

160

3.30

13.97

1.5

1.4

4579.46

97872.23

e6/l

1.21

119

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

337

2.55

13.97

1.6

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

251

1515

1.74

13.92

3.7

3.5

5.89

5.81

kpa

0.59

244

1477

(3020876) Protein [Mass/time] in 24 hour Urine

181

3.15

13.89

2.2

2.6

1.41

1.34

g/24h

0.07

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

5.05

13.84

4.6

4.5

—

(3002385) Erythrocyte distribution width [Ratio]

1867

16967

1.51

13.55

28.6

15.4

15.04

14.86

0.75

1857

16670

(3042111) Morphology [Interpretation] in Bone marrow Narrative

285

2.65

13.38

1.4

1.6

—

(3002032) Base excess in Venous blood by calculation

247

1501

1.72

13.36

3.8

3.5

2.34

1.97

mmol/l

0.91

218

1270

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

116

3.67

13.30

1.2

1.1

0.39

6.23

nmol/l

0.64

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

113

530

2.19

13.22

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

236

2.80

13.16

2.1

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

144

744

2.00

13.05

2.4

1.9

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

165

897

1.90

12.89

9.5

9.2

24.06

24.40

mmol/l

0.82

160

877

(3019060) Gas panel - Arterial blood

190

1082

1.82

12.83

5.5

5.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

169

3.12

12.80

1.4

2.1

—

(3000492) Spirometry study

294

1891

1.63

12.80

1.9

1.4

—

(3013512) EKG study

691

5328

1.42

12.69

4.4

3.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

224

2.82

12.68

1.6

1.4

—

(3022313) Gas panel - Capillary blood

144

752

1.98

12.67

4.8

3.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

276

2.62

12.62

1.4

1.3

—

(3044889) 12 lead EKG panel

1527

13442

1.40

12.57

4.7

3.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

180

1020

1.83

12.35

1.6

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

183

1048

1.81

12.13

7.8

7.1

25.13

24.49

mmol/l

1.30

173

991

(4200892) Spirometry reversibility

220

1332

1.72

12.04

1.7

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

4.02

11.92

1.5

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

4.02

11.92

1.5

1.3

—

(3028433) Virus identified in Specimen by Culture

4.86

11.90

1.2

1.3

—

(3042733) HLA Ab [Presence] in Serum

5.88

11.80

7.4

4.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

129

669

1.98

11.59

2.2

1.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

246

1554

1.65

11.47

1.3

1.2

143.68

148.39

iu/ml

0.06

599

(3000060) B lymphocytes [#/volume] in Blood

5.41

11.35

2.0

2.1

130.71

143.33

e6/l

0.08

(3017704) Immunofixation for Urine

3.78

11.30

1.3

1.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2179

20719

1.81

11.14

20.2

9.9

24.46

24.91

u/l

0.83

2159

20030

(3019550) Sodium [Moles/volume] in Serum or Plasma

2109

19877

1.65

11.14

23.4

14.5

139.35

139.69

mmol/l

7.01

2077

19374

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

264

2.54

11.11

1.6

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

139

3.13

10.73

1.0

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1079

9122

1.34

10.71

3.1

2.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

528

3984

1.42

10.66

1.7

1.6

462.85

36016108.10

pmol/l

3.96

459

3318

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.29

10.59

1.3

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

4.65

10.47

1.6

1.4

44.53

44.03

0.02

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

333

2306

1.52

10.44

8.3

6.4

—

(21494434) Karyotype in Bone marrow

152

3.00

10.43

1.1

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2110

19939

1.62

10.40

23.6

14.7

3.93

3.95

mmol/l

1.53

2075

19402

(3000570) Elastase.pancreatic [Mass/mass] in Stool

112

576

1.99

10.33

1.3

1.4

315.59

297.84

ug/g

0.40

311

(4035726) Immunohistochemistry procedure

266

1757

1.58

10.31

1.5

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

112

3.34

10.27

1.4

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

293

2.40

10.25

1.1

3.71

2.12

u/ml

0.66

139

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

143

3.04

10.24

1.2

1.1

36.83

39.43

mg/l

0.19

119

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

101

503

2.05

10.18

1.4

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

183

2.77

10.04

1.3

31.78

33.88

g/l

0.47

161

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

135

3.07

9.94

1.1

240.97

247.59

mg/l

0.08

118

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.51

9.90

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.51

9.90

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1973

18415

1.47

9.88

20.3

11.9

83.63

82.46

ml/min/173m2

1.59

1765

15181

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

100

3.44

9.87

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

299

2.35

9.81

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

306

2.33

9.76

1.0

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

418

2.12

9.65

1.2

1.3

3.67

3.74

mmol/l

0.23

397

(3003181) Sodium [Moles/volume] in Urine

314

2.30

9.64

1.4

1.3

58.62

61.63

mmol/l

0.26

260

(40768446) Kidney Pathology biopsy report

4.46

9.55

1.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.62

9.53

1.4

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

502

2.02

9.52

4.1

3.6

0.34

0.37

u/ml

0.34

282

(1761868) Lipid panel - Serum or Plasma

562

7075

0.73

9.42

2.8

2.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

184

2.70

9.40

2.3

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.77

9.33

1.3

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

399

2.12

9.21

1.5

1.9

4.20

5.11

mmol/24h

1.95

349

(3023199) Leukocytes [#/volume] in Pleural fluid

170

2.74

9.10

1.3

4620.46

2524.25

e6/l

0.49

114

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

166

1009

1.69

8.96

7.3

6.6

24.89

24.96

mmol/l

0.10

166

1004

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

417

2.08

8.96

1.4

1.5

266.53

1389.05

e6/l

0.95

335

(3000330) Specific gravity of Urine by Test strip

158

948

1.72

8.95

4.0

3.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

197

1253

1.63

8.93

3.3

2.8

4.81

4.60

kpa

0.32

191

1218

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

172

2.71

8.91

3.1

3.6

—

(3045788) Cell count panel - Pleural fluid

139

2.91

8.87

1.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

4.35

8.87

1.9

2.7

143.54

54.06

au/ml

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

270

2.33

8.75

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

417

2.05

8.59

1.4

8.46

22.74

e6/l

0.97

314

(3045142) Bone marrow Pathology biopsy report

205

2.52

8.57

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

182

2.61

8.52

1.0

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

586

4651

1.35

8.43

2.8

2.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

171

1066

1.65

8.40

10.4

8.7

93.87

94.09

0.20

171

1061

(3028308) Erythrocytes [#/volume] in Pleural fluid

149

2.78

8.40

1.2

1.3

116926.88

110292.44

e6/l

0.03

(3024263) Appearance of Synovial fluid

3.40

8.35

1.3

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

115

642

1.83

8.34

1.7

—

(3045424) Erythrocytes [Presence] in Urine

322

2.18

8.29

1.8

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

240

2.37

8.21

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

102

551

1.89

8.20

3.1

3.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1439

12929

1.30

8.17

3.4

3.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

305

2.20

8.13

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

3.59

8.13

1.0

1.1

301.28

184.78

iu/ml

0.36

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

490

3804

1.36

8.09

1.6

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

224

1503

1.54

8.08

4.2

3.5

1.23

mmol/l

0.29

211

1300

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

147

893

1.69

7.97

12.4

10.3

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

7.25

7.95

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

423

2.00

7.92

1.2

1.4

—

(40768441) Liver Pathology biopsy report

137

2.80

7.91

1.4

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

128

2.84

7.70

1.8

1.6

4.00

5.73

u/l

0.43

106

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

3.55

7.69

1.3

1.1

0.30

0.29

g/l

0.25

(3022145) Colonoscopy Study observation

303

2184

1.45

7.69

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.99

7.61

2.5

2.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

206

2.41

7.53

2.0

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

206

2.41

7.53

2.0

1.3

—

(3037121) Protein [Mass/volume] in Urine

109

621

1.79

7.43

2.5

3.2

0.39

0.26

g/l

0.48

237

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

310

2.13

7.43

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

178

2.50

7.34

1.3

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

217

2.33

7.17

1.4

1.7

—

1506.67

—

(3044640) Blood type and Crossmatch panel - Blood

736

6149

1.29

7.11

2.9

2.2

—

(3047181) Lactate [Moles/volume] in Blood

534

1.83

7.09

6.6

7.3

1.39

1.26

mmol/l

0.72

465

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

154

980

1.61

7.00

2.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

113

2.86

6.95

1.4

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

255

1813

1.46

6.95

2.4

2.3

38.75

37.19

u/l

0.09

220

1543

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

108

2.90

6.90

1.1

1.34

1.08

u/l

0.45

(3035637) Corticotropin [Mass/volume] in Plasma

215

2.31

6.87

1.7

1.6

—

(3025941) Bacteria identified in Stool by Culture

176

1162

1.56

6.84

1.3

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

202

1378

1.51

6.76

3.0

3.2

4.31

4.47

pmol/l

1.43

188

1228

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

16.73

6.74

1.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1422

12905

1.26

6.73

3.9

3.0

55.04

44.60

u/l

2.30

1345

12072

(3012441) Differential panel - Pleural fluid

144

2.59

6.70

1.2

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.23

6.70

1.4

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.23

6.70

1.4

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.23

6.70

1.5

1.6

—

(3019174) dRVVT (LA screen)

6.85

6.51

1.3

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

196

2.32

6.44

2.4

2.5

—

(3024471) HLA-A [Type]

3.94

6.44

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

184

2.36

6.40

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

136

2.60

6.37

1.5

1.3

—

(40767503) Oxygen content in Capillary blood by calculation

330

2.00

6.34

3.5

2.4

15.92

16.37

0.38

157

(3032773) Endomysium IgG Ab [Titer] in Serum

161

2.45

6.28

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

7.03

6.21

1.4

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.98

6.16

1.1

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

228

2.17

6.02

1.0

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.83

5.83

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.80

5.81

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

101

607

1.69

5.78

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

3.35

5.72

34.9

29.3

7.03

7.68

ug/l

0.50

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

214

2.17

5.67

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

302

1.98

5.66

1.1

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

108

665

1.65

5.65

5.4

3.6

24.68

24.96

mmol/l

0.45

100

615

(3034891) Synovial lining cells/100 cells in Synovial fluid

3.05

5.65

1.7

1.3

2.29

4.60

—

(42529406) Shigella sp [Presence] in Stool by Culture

102

619

1.68

5.64

1.3

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.35

5.44

2.1

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

160

2.33

5.43

1.1

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

100

611

1.67

5.40

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.19

5.32

1.1

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

107

2.64

5.31

1.9

1.4

—

(3009015) Lactate [Moles/volume] in Synovial fluid

6.69

5.25

1.3

1.4

5.02

5.92

mmol/l

—

(1616796) Gas panel - Central venous blood

347

1.87

5.21

5.1

3.6

—

(3020891) Body temperature

107

672

1.62

5.20

4.9

4.1

—

(3019977) pH of Arterial blood

2.81

5.14

2.1

3.3

7.45

7.43

1.16

(40768806) Pleura Pathology biopsy report

159

2.28

5.05

1.3

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

133

886

1.53

5.03

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.71

5.01

2.0

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

2.64

4.98

1.7

2.2

99.65

102.79

0.17

(3012516) Albumin [Mass/volume] in Urine

616

5230

1.24

4.87

3.5

3.2

822.17

341.17

mg/l

0.99

403

3195

(3044290) Cell count panel - Cerebral spinal fluid

388

1.78

4.73

1.4

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

127

2.38

4.65

1.1

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

657

5642

1.23

4.64

3.5

3.1

6.75

7.12

mmol/l

1.44

570

4801

(3008536) Aspergillus sp Ab [Presence] in Serum

5.02

4.63

1.5

2.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

377

1.77

4.58

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

377

1.77

4.58

1.5

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.54

4.55

2.0

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

10.03

4.52

1.1

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

129

2.34

4.50

2.0

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.60

4.47

2.0

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.28

4.47

1.2

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

146

1018

1.46

4.46

3.6

2.9

123.84

127.55

g/l

1.33

141

995

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

104

675

1.57

4.45

6.4

6.1

1.64

1.56

0.47

630

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

175

2.13

4.45

1.1

—

(21494755) Public health laboratory ask at order entry panel

135

1919

0.69

4.38

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

7.52

4.35

1.1

1.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.89

4.33

1.1

1.2

101.32

114.95

1.10

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.89

4.33

1.0

1.1

94.21

91.06

0.16

(3024932) HLA-DR beta [Type]

3.35

4.32

1.0

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

116

777

1.52

4.32

3.7

2.9

25.79

25.44

mmol/l

0.42

111

756

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

129

1839

0.68

4.26

1.8

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

3.05

4.24

1.4

1.2

37.29

38.17

g/l

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

108

2.42

4.22

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.82

4.18

1.0

2.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

511

1.63

4.18

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.94

4.16

1.2

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.26

4.14

2.7

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

554

1.59

4.07

1.5

1.9

112.17

4.57

iu/l

0.49

202

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1853

17680

1.24

4.06

5.8

5.4

38.56

39.35

mmol/mol

3.56

1766

16391

(3043409) Potassium [Moles/volume] in Arterial blood

515

1.61

4.06

4.6

3.5

3.87

3.83

mmol/l

0.39

509

(3027456) Digoxin [Moles/volume] in Serum or Plasma

333

1.76

4.00

3.2

3.1

0.75

0.82

nmol/l

0.65

260

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

253

1.88

3.99

1.4

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

102

677

1.53

3.99

6.5

6.1

0.93

0.91

0.27

632

(3011048) Pyruvate [Moles/volume] in Blood

6.45

3.98

1.4

1.2

84.00

81.07

umol/l

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

3.03

3.96

1.4

2.2

9.41

10.34

mg/l

0.22

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

100

2.41

3.89

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.78

3.85

1.0

1.4

95.62

94.47

0.05

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

249

1.86

3.85

1.3

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

139

2.17

3.83

1.9

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

194

1.97

3.78

1.1

1.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

8.77

3.77

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

2.74

3.75

1.5

1.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1245

0.65

3.74

1.6

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.65

3.73

1.4

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

252

1.84

3.72

1.3

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

631

5499

1.20

3.72

4.2

3.7

15.03

8.48

mg/mmol

1.51

411

3347

(3026480) Teichoate Ab [Titer] in Serum

6.68

3.67

1.0

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

6.68

3.67

1.5

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

246

1.85

3.67

1.4

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

246

1.85

3.67

1.4

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

149

2.10

3.63

1.1

1.5

13.11

11.78

umol/l

0.55

140

(3005988) Vibrio sp identified in Specimen by Organism specific culture

248

1.83

3.58

1.4

1.5

—

(3035880) pH of Pleural fluid

2.51

3.38

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.01

3.37

1.1

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

175

1.96

3.34

1.4

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.42

3.30

1.4

1.2

—

(40765096) Chromosome analysis panel by Banding

2.93

3.30

1.3

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.93

3.30

1.0

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.45

3.21

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.45

3.21

1.3

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

228

1.81

3.20

2.5

2.2

33.50

25.78

mg/l

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.28

3.19

1.3

—

(3039000) Anion gap in Blood

372

1.63

3.19

8.1

9.0

10.46

11.16

mmol/l

0.82

333

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.18

3.19

1.0

—

(3001729) Color of Synovial fluid

5.35

3.19

1.1

1.9

—

(3018572) Chloride [Moles/volume] in Blood

373

1.62

3.16

8.1

9.0

104.31

104.99

mmol/l

0.37

334

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

166

1.94

3.09

1.2

1.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.01

3.08

1.1

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.01

3.08

1.0

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.34

3.08

1.1

1354.53

1639.40

miu/ml

0.68

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

536

1.51

3.07

1.2

—

(3008295) Osmolality of Serum or Plasma

195

1.86

3.07

1.7

1.4

276.60

278.29

mosm/kgh2o

0.18

150

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.23

3.06

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

109

777

1.42

3.05

1.7

1.6

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

7.52

3.05

1.2

1.0

—

(3003338) MCHC [Mass/volume]

1745

16690

1.18

3.04

32.4

16.6

329.86

331.71

g/l

14.20

1736

16574

(3000012) Reticulocyte production index

225

1.79

3.03

2.1

2.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

106

2.18

3.03

1.1

1.6

9.44

8.12

ug/l

0.13

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.85

3.02

1.0

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

3.35

3.01

1.8

1.4

17.40

25.04

—

(3051611) Lipemic interference index of Serum or Plasma

199

1.82

2.90

3.0

3.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.45

2.90

1.0

1.2

478.53

42.95

ug/l

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.70

2.89

1.1

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.70

2.89

1.1

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

4.10

2.88

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

5.40

2.87

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

456

1.53

2.84

1.3

1.4

12.18

12.15

u/l

0.01

368

(3004716) Salmonella sp identified in Stool by Organism specific culture

145

1100

1.34

2.81

1.5

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.34

2.81

1.1

1.2

—

(40761511) CBC panel - Blood by Automated count

2089

20361

1.25

2.78

20.7

12.1

—

(3024869) Neuronal Ab [Presence] in Serum

3.92

2.77

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.25

2.70

1.1

2.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

6.01

2.70

1.2

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.76

2.67

1.0

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

356

1.56

2.52

3.3

2.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

122

1.98

2.50

1.3

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

129

1.95

2.50

1.4

1.5

68.60

75.64

umol/l

0.92

129

(44816559) Phosphatidylethanol [Mass/volume] in Blood

341

1.57

2.49

1.1

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.82

2.46

1.1

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.39

2.46

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

482

4251

1.17

2.38

1.5

1.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

6.26

2.37

1.0

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

132

1.90

2.36

1.0

1.4

—

24.71

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.04

2.35

1.9

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

258

2155

1.22

2.34

1.5

1.7

1.45

1.41

0.32

228

1899

(3012501) Base excess in Blood by calculation

373

1.51

2.28

6.2

3.9

2.60

2.64

mmol/l

0.04

256

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1941

18852

1.18

2.28

4.6

4.4

5.71

5.86

mmol/l

5.47

1821

17265

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.95

2.28

1.2

1.1

—

(40757373) Influenza virus identified in Isolate

2.95

2.28

2.3

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.76

2.27

1.2

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.76

2.27

1.2

1.3

0.64

4.36

1.19

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.56

2.27

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.56

2.27

1.1

—

(40761536) Microorganisms panel - Urine sediment

198

1617

1.25

2.23

7.3

3.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

223

1845

1.23

2.23

4.1

3.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

343

1.53

2.22

1.5

1.4

13.74

27.95

u/l

5.06

285

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.10

2.22

1.2

2.2

17.26

18.82

ug/l

0.17

(3006270) Folate [Moles/volume] in Blood

157

1.79

2.21

1.3

1.1

330.79

396.37

nmol/l

0.94

145

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.69

2.20

1.0

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

910

0.69

2.20

1.4

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

114

1.94

2.20

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.34

2.18

1.3

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

122

1.89

2.16

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

115

1.92

2.15

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

4.29

2.15

1.2

1.1

—

(4212803) Bone marrow aspirate examination

4.29

2.15

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

743

1.35

2.13

2.0

2.1

11.32

11.43

nmol/l

0.04

669

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.57

2.08

1.1

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

147

1.78

2.02

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

2199

21655

1.28

2.00

37.5

19.2

39.49

39.80

1.99

2088

20368

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

170

1.71

2.00

2.0

2.6

—

(3023410) Appearance of Cerebral spinal fluid

193

1.67

2.00

1.3

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

134

1.80

1.95

1.5

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.19

1.94

1.4

1.3

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.97

1.93

1.1

3.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

158

1.72

1.89

1.2

1.4

10.50

8.66

mmol/l

0.60

153

(3024731) MCV [Entitic volume]

2200

21680

1.27

1.88

37.2

19.1

91.48

90.92

6.35

2189

21396

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.19

1.88

3.0

2.2

—

(3010813) Leukocytes [#/volume] in Blood

2200

21682

1.27

1.86

37.4

19.2

6.50

6.62

e9/l

1.39

2171

21108

(3007461) Platelets [#/volume] in Blood

2199

21671

1.27

1.86

37.5

19.2

260.48

258.40

e9/l

0.75

2175

21159

(3035941) MCH [Entitic mass]

2200

21683

1.27

1.85

37.2

19.1

30.24

30.22

0.18

2189

21396

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

277

1.53

1.84

1.3

1.2

74.60

23.73

u/l

0.63

238

(3026361) Erythrocytes [#/volume] in Blood

2200

21684

1.27

1.84

37.4

19.1

4.37

4.45

e12/l

15.02

2171

21117

(3000963) Hemoglobin [Mass/volume] in Blood

2200

21691

1.26

1.78

37.6

19.2

131.08

133.82

g/l

18.40

2191

21405

(3047189) Immunofixation for 24 hour Urine

1.94

1.74

1.2

1.6

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.34

1.74

1.2

1.1

19.83

27.86

u/l

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.23

1.74

1.5

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.67

1.72

1.1

1.2

71.13

85.11

ng/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.92

1.72

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.14

1.71

3.3

2.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

133

1.74

1.70

1.5

1.3

—

(3017569) Oxygen content in Arterial blood

1.96

1.69

4.4

2.7

—

(3024928) Oxygen saturation in Venous blood

358

1.43

1.68

2.6

2.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.81

1.65

1.4

1.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.45

1.64

1.0

1.2

—

(3048879) Bone marrow aspiration report

2.25

1.63

1.1

2.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

213

1.56

1.62

2.6

4.4

19.24

94.20

u/ml

1.44

(3038177) Helicobacter pylori Ab [Presence] in Serum

344

1.43

1.62

1.3

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.95

1.59

3.3

2.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

354

1.42

1.59

1.5

1.4

0.33

0.35

nmol/l

0.09

268

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.00

1.58

3.7

2.3

—

(3006462) Nitrate [Presence] in Urine

1.85

1.56

5.1

3.0

—

(3002256) Pathology report gross observation

291

2558

1.16

1.53

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

161

1.62

1.52

1.2

0.20

0.75

u/ml

1.11

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.34

1.52

1.0

2.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

210

1800

1.18

1.52

1.5

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

225

1.52

1.51

1.5

1.6

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

2.01

1.48

1.5

2.6

140.00

146.25

0.15

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.44

1.48

1.6

3.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

330

0.60

1.47

1.4

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

664

1.29

1.46

1.6

1.3

158.59

224.19

miu/ml

1.01

335

(3023323) Follitropin [Units/volume] in Serum or Plasma

145

1206

1.22

1.46

1.4

1.3

31.52

30.75

iu/l

0.10

125

1032

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.50

1.45

1.3

3.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.13

1.44

1.0

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

227

0.53

1.43

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

652

1.28

1.38

3.2

3.5

17.26

2202.03

u/ml

0.83

566

(3035320) C reactive protein [Mass/volume] in Body fluid

142

1.63

1.38

2.4

2.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.80

1.37

3.9

2.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.94

1.36

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

349

1.38

1.35

1.1

5.60

4.25

u/ml

0.22

167

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

159

1.58

1.34

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.04

1.32

1.0

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

227

1.46

1.26

1.0

1.1

—

(3011985) Renin [Units/volume] in Plasma

252

1.44

1.26

1.7

1.4

48.40

43.01

mu/l

0.14

230

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

523

0.72

1.20

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

102

1.67

1.16

1.1

1.4

134.53

132.98

nmol/l

0.04

102

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.50

1.15

2.8

6.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

402

0.69

1.14

1.5

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.69

1.13

1.7

—

(3014271) Vancomycin [Susceptibility]

1.75

1.13

3.7

2.9

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

113

0.44

1.12

22.0

12.1

649.20

856.61

nmol/l

—

108

(3002523) Influenza virus A Ag [Presence] in Specimen

319

1.35

1.11

1.1

—

(3022689) Creatine [Moles/volume] in Urine

1.96

1.11

1.2

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.26

1.10

6.6

9.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

337

1.34

1.10

1.1

0.19

1.30

u/ml

1.84

135

(3005033) Fetal Nuchal fold Thickness US

399

0.70

1.10

1.5

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.38

1.09

20.2

9.4

5.52

6.04

mmol/l

—

(3051593) INR in Capillary blood by Coagulation assay

1.76

1.06

14.5

10.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

778

1.22

1.05

2.2

2.1

5006.86

4097.59

u/l

0.08

322

(3035933) Granulocytes/100 leukocytes in Blood

1.84

1.02

1.4

1.3

—

(3004451) EKG impression Narrative

1.74

1.02

1.5

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

404

1.29

1.01

4.7

3.6

29.34

25.27

mg/l

0.39

256

(3043238) Trisomy 21 risk [Likelihood] in Fetus

414

0.72

1.00

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

216

1927

1.13

0.98

3.1

4.1

3.06

22.99

ug/l

3.46

163

1537

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.97

0.0

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.80

0.96

1.7

2.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.80

0.96

1.7

2.9

—

(4281824) Cell count and differential, peritoneal fluid

269

0.67

0.93

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

487

0.76

0.92

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.15

0.91

4.5

9.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

486

0.76

0.91

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

485

0.76

0.90

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

484

0.76

0.89

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

136

1.47

0.86

1.3

1.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

317

1.30

0.85

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.67

0.85

1.5

3.1

65.67

172.30

umol/l

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.94

0.84

2.5

1.6

1.21

mmol/l

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.94

0.84

1.3

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.78

0.84

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

389

1.27

0.84

1.1

2.12

2.31

u/ml

0.05

193

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.70

0.82

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

113

1.51

0.82

1.4

1.3

—

(3015183) Erythrocyte sedimentation rate

113

1.51

0.82

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.58

0.81

1.0

—

(3020650) Glucose [Presence] in Urine

1.70

0.75

1.1

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

414

1.24

0.74

2.3

2.4

33.57

102.01

ug/min

2.55

252

(3000285) Sodium [Moles/volume] in Blood

2.09

0.74

2.0

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1952

19261

1.08

0.73

4.5

4.3

4.63

4.78

mmol/l

10.33

1855

17957

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1872

18445

1.08

0.72

4.1

3.8

1.22

1.27

mmol/l

2.99

1766

16982

(3011648) Oxygen content in Venous blood

142

1.41

0.72

2.4

2.0

11.61

10.85

0.49

142

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

117

1.46

0.71

1.0

1.3

—

679.00

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.75

0.71

1.4

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.75

0.71

1.3

2.3

21.49

19.12

umol/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

444

0.79

0.71

1.5

—

(3049717) Cytology report of Urine Cyto stain

564

1.19

0.70

2.2

2.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.71

0.70

1.0

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

331

0.75

0.69

1.7

—

(3033799) Differential panel - Peritoneal fluid

1.53

0.68

2.3

1.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1940

19154

1.08

0.67

4.5

4.2

1.55

1.53

mmol/l

1.05

1835

17756

(3028707) Methadone [Presence] in Urine by Screen method

306

0.75

0.67

1.3

2.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.49

0.66

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.79

0.66

1.0

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

254

2350

1.09

0.64

4.1

4.3

35.90

32.71

4.73

200

1604

(3021387) Prolactin [Units/volume] in Serum or Plasma

700

1.16

0.64

1.7

1.6

278.45

314.57

mu/l

0.65

632

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

393

0.79

0.64

1.6

1.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.73

0.64

2.6

2.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

146

1.37

0.63

1.7

2.2

1.33

2.37

u/field

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

125

1115

1.13

0.63

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

164

1.34

0.62

3.0

2.6

14.81

25.21

mg/l

0.54

117

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

147

1.36

0.61

1.6

2.0

15.71

19.02

nmol/l

1.65

139

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

1.46

0.61

1.1

1.4

—

73.82

—

(3001019) Free T4 and TSH panel - Serum or Plasma

113

1268

0.89

0.61

1.8

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

149

1347

1.11

0.61

1.8

—

(40768795) Lymph node Pathology biopsy report

200

1.30

0.60

1.5

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.50

0.59

1.3

1.6

—

808258.33

iu/ml

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

319

1.23

0.57

1.1

0.45

1.75

u/ml

2.52

159

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

181

1967

0.91

0.55

1.8

2.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.62

0.55

1.2

—

4.30

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.54

0.55

1.5

1.2

109.13

145.70

pmol/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

249

1.25

0.54

1.1

2.70

4.19

u/ml

0.48

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

231

1.26

0.54

1.1

0.05

0.34

u/ml

1.25

(40768800) Prostate Pathology biopsy report

170

0.70

0.53

1.1

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.54

0.53

4.5

3.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.52

0.52

1.9

1.1

—

14.00

—

(3020874) Milk IgE Ab [Units/volume] in Serum

117

1.37

0.52

1.0

1.1

0.20

0.85

u/ml

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.50

0.51

1.2

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

296

1.22

0.51

2.0

1.6

52.44

42.48

nmol/l

0.81

287

(3027008) Opiates [Presence] in Urine

655

0.87

0.47

1.3

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

101

911

1.11

0.46

1.4

—

(44813793) Dust mix specific IgE antibody measurement

155

1.29

0.46

1.2

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1977

19591

1.06

0.46

4.9

4.7

2.68

2.83

mmol/l

12.03

1872

18157

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

822

0.88

0.45

1.4

1.7

7.97

4.04

mg/l

0.67

604

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

116

1057

1.10

0.45

1.7

—

(3016879) Cocaine [Presence] in Urine

608

0.87

0.44

1.3

1.8

—

(40758292) HTLV I+II Ab panel - Serum

1.61

0.43

1.2

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

196

0.76

0.42

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.43

0.42

1.4

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

122

1.31

0.42

1.0

—

(3044007) Cell count panel - Peritoneal fluid

1.40

0.42

1.5

2.1

—

(3028300) Cannabinoids [Presence] in Urine

658

0.88

0.41

1.3

1.7

—

(3005570) Glucose [Moles/volume] in Urine

213

1.22

0.40

2.2

2.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

542

5236

1.05

0.40

1.6

1.7

1.34

1.37

mmol/l

0.46

480

4445

(3027944) Amphetamines [Presence] in Urine

644

0.88

0.39

1.3

1.7

—

(3002619) Bacteria identified in Specimen by Culture

1.43

0.39

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

1.43

0.39

1.8

1.9

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.43

0.39

1.0

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

601

0.88

0.39

1.5

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

653

0.89

0.38

1.3

1.7

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.39

0.37

1.6

1.5

15.00

14.20

pmol/l

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

146

1363

1.08

0.35

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

134

0.75

0.35

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

447

0.87

0.34

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.36

0.34

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.31

0.33

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

101

1.29

0.31

1.3

1.4

1.44

1.25

nmol/l

0.26

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

314

1.15

0.31

1.1

133.43

1781.44

iu/ml

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

100

0.70

0.30

1.0

1.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

120

1.25

0.30

1.2

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

210

2204

0.95

0.30

1.8

2.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

567

0.90

0.29

1.5

1.7

—

(3003694) ABO and Rh group [Type] in Blood

548

5338

1.03

0.28

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.30

0.28

1.3

128.91

151.07

mmol/24h

0.53

(1001926) Buprenorphine [Presence] in Urine by Screen method

511

0.90

0.27

1.3

1.7

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

138

0.80

0.25

1.3

1.6

7.62

7.91

mmol/l

0.44

131

(1002224) Polysomnography panel

823

1.07

0.23

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

659

1.08

0.23

1.8

1.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

275

1.13

0.23

1.1

5.28

3.03

u/ml

0.24

126

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

213

2214

0.96

0.22

1.8

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

289

2801

1.04

0.21

4.4

4.8

2.19

2.64

ug/l

0.51

255

2486

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

156

1630

0.95

0.21

2.8

3.0

0.66

0.76

ug/l

0.54

106

1055

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.21

0.0

1.0

—

21.83

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.16

0.21

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

7.95

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

114

0.79

0.20

1.2

1.4

5.46

5.87

mmol/l

—

108

(3041806) Other cells [#/volume] in Blood by Manual count

1.18

0.19

1.8

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

249

0.88

0.19

1.1

1.4

2.92

3.98

ug/l

0.40

217

(3034274) Bile acid [Moles/volume] in Serum --fasting

251

1.12

0.18

2.3

2.1

5.43

6.32

umol/l

0.26

176

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

251

1.12

0.18

1.5

1.2

—

nmol/l

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

262

1.11

0.17

1.4

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

226

1.11

0.15

2.8

3.4

4.72

5.53

nmol/l

0.19

218

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

201

1956

1.03

0.14

1.5

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

133

1.13

0.12

3.8

6.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

220

2250

0.98

0.12

4.0

4.2

21.97

21.25

0.28

1035

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

106

1.13

0.09

1.7

1.3

—

(3025130) Human papilloma virus identified in Specimen

350

0.94

0.09

2.2

1.8

—

(4146454) Self-monitoring of blood glucose

194

1.08

0.09

2.8

2.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

277

0.94

0.08

3.5

5.4

366.65

370.52

umol/l

0.05

239

(40768793) Breast Pathology biopsy report

612

0.96

0.08

1.2

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

491

1.04

0.07

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

157

1.08

0.07

1.9

1.4

0.83

0.96

g/l

1.01

157

(3033705) Calcium.ionized [Moles/volume] in Venous blood

200

1.05

0.03

3.8

2.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

449

1.02

0.03

5.5

4.1

—

(3011288) Drugs identified in Urine by Screen method

440

0.98

0.02

1.7

2.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

168

0.95

0.02

1.9

1.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

302

1.03

0.02

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

233

1.03

0.01

1.3

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

138

1.01

0.00

1.6

1.3

1.60

1.61

g/l

0.04

138

(3051651) Icteric interference index of Serum or Plasma

116

1.03

0.00

3.8

3.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.01

0.00

2.7

1.3

—

(4034850) Laboratory test

647

1.00

0.00

16.0

9.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

112

0.98

0.00

1.6

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

367

1.01

0.00

2.1

2.2

0.77

0.83

nmol/l

0.41

305

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

15.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.4

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.92

-0.00

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(3007733) Chloride [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

90.33

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.93

-0.00

3.0

1.5

90.46

85.38

nmol/24h

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.4

—

164.60

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_CONNECTNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_CONNECTNAS	1.701 [1.54, 1.88]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.266

During the follow-up period (1.1.1998 — 31.12.2019), 1412 out of 7588 females with M13_CONNECTNAS died.

Males

Parameter	HR [95% CI]	p-value
M13_CONNECTNAS	1.857 [1.6, 2.16]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.012

During the follow-up period (1.1.1998 — 31.12.2019), 678 out of 2013 males with M13_CONNECTNAS died.

Mortality risk

Mortality risk for people of age

years, who have M13_CONNECTNAS.

N-year risk	Females	Males
1	0.156%	0.352%
5	0.931%	1.948%
10	2.497%	5.225%
15	4.892%	9.977%
20	8.538%	16.941%

Relationships between endpoints

↥

Index endpoint: M13_CONNECTNAS – Other specified/unspecified systemic involvement of connective tissue

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other specified/unspecified systemic involvement of connective tissue

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints